The information in this Annual Report contains forward-looking
statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),
and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the “safe
harbor” created by those sections. The words “anticipates,” “believes,” “estimates,” “expects,”
“intends,” “may,” “plans,” “projects,” “will,” “should,” “could,”
“predicts,” “potential,” “continue,” “would” and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the
plans, intentions or expectations disclosed in the Company’s forward-looking statements and you should not place undue reliance
on the Company’s forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations
disclosed in the forward-looking statements that we make. The forward-looking statements are applicable only as of the date on which they
are made, and we do not assume any obligation to update any forward-looking statements. All forward-looking statements in this Annual
Report on Form 10-K are made based on the Company’s current expectations, forecasts, estimates and assumptions, and involve risks,
uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements.
In evaluating these statements, you should specifically consider various factors, uncertainties and risks that could affect the Company’s
future results or operations. These factors, uncertainties and risks may cause the Company’s actual results to differ materially
from any forward-looking statement set forth in this Annual Report on Form 10-K. You should carefully consider these risk and uncertainties
described and other information contained in the reports we file with or furnish to the Securities and Exchange Commission (the “SEC”)
before making any investment decision with respect to the Company’s securities. All forward-looking statements attributable to us
or persons acting on the Company’s behalf are expressly qualified in their entirety by this cautionary statement.
ITEM 1. BUSINESS.
ORGANIZATION AND INITIAL PUBLIC OFFERING
Deep Medicine Acquisition Corp. (the “Company,”
“we,” “us” and “our”) is a blank check company incorporated on July 8, 2020, under the laws of the
State of Delaware for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or other similar business combination with one or more businesses or entities (a “Business Combination”). While the Company
may, subject to certain limitations, pursue a Business Combination target with operations or prospects in the digital healthcare and artificial
intelligence (AI) in medicine sector in the global market.
As of March 31, 2022, the Company had not commenced
any operations. All activity for the period from July 8, 2020 (inception) through March 31, 2022, relates to the Company’s formation
and its initial public offering (“IPO”), which is described below, and subsequent to its IPO, identifying a target company
for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the cash and marketable securities
held in the Trust Account (as defined below). The Company has selected March 31 as its fiscal year end.
On October 29, 2021, the Company consummated its IPO
of 12,650,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units, the “Public
Shares”) at $10.00 per unit, which included 1,650,000 Units issued pursuant to the full exercise by the Underwriters (as defined
below) of their over-allotment option, and the private sale of an aggregate of 519,500 Units (the “Private Placement Units”
and with respect to the shares of Class A common stock included in the Units, the “Private Placement Shares”) to its sponsor,
Bright Vision Sponsor LLC (the “Sponsor”) and I-Bankers Securities, Inc. (“I-Bankers” or “Underwriters”)
at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds of $5,195,000 to the Company that closed simultaneously
with the closing of the IPO (see Note 3). The Company’s securities have been listed on the Nasdaq Global Market (“Nasdaq”).
On December 2, 2021, the Company’s Units no longer traded, and shares of the Company’s Class A common stock and rights underlying
the Units commenced trading separately.
Transaction costs amounted to $7,282,500 consisting
of $2,530,000 in cash of underwriting commissions, $4,427,500 of business combination marketing fee, and $325,000 of other offering costs.
Upon the closing of the IPO on October 29, 2021, the
Company deposited $127,765,000 ($10.10 per Unit) from the proceeds of the IPO and certain proceeds of the sales of Private Placement Units
in the trust account (“Trust Account”), located in the United States and invested only in U.S. government securities, within
the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment
company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment
Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution
of the funds held in the Trust Account, as described below.
Following the closing of the IPO, cash of $764,101
was held outside of the Trust Account (as defined below) and is available for working capital purposes. As of March 31, 2022, the Company
had available cash of $877,099 on its balance sheet and working capital of $655,693.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially
all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the
Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more
operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust
Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting
commissions) at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The
Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting
securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).
PROPOSED BUSINESS
General
We are a blank check company incorporated on
July 8, 2020 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination
target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business
combination target. We intend to effectuate our initial business combination using cash from the proceeds of the IPO and the private placement
of the private placement units, the proceeds of the sale of our shares in connection with our initial business combination (including
pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the IPO or otherwise),
shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
While we may pursue an acquisition or a business
combination target in any business or industry, we intend to concentrate our efforts in identifying a target in the healthcare industry
with an equity value of approximately $300 million to $1 billion. The healthcare industry, the focus of our company, has been
chosen due to the myriad of the opportunities it offers, as well as our deep expertise in it that can be a source of significant competitive
advantage.
In addition to being the largest sector of the
world economy, the healthcare sector is also the fastest growing. This is due to a number of demographic, technological, and economic
reasons. The aging global population means that people live longer to develop many “old-age” chronic diseases such as hypertension,
heart disease, cancer, and many other diseases. There has been significant progress in the ability to manage these diseases over the last
century. In 1970, the probability of dying from a heart attack was over 30%, while today it is less than 5%. Hairy cell leukemia was universally
fatal in the late 90’s, while today most patients are cured with the first round of chemotherapy. The pace of innovation in medical
science has accelerated due to the increase in global wealth and the available funding for research, better equipment and techniques,
and increased sophistication in designing clinical trials. Also, increased consumerism in healthcare means that the use of healthcare
services has continued to rise along with the rise in consumer wealth and education.
Most recently, there has been significant interest
and research in the use of digital technologies in all aspects of healthcare. This spans translational medical research, clinical trials,
telehealth, disease management, patient monitoring, and more. One of the key drivers of this trend was the Affordable Care Act, that provided
significant funds for the adoption of the EHR. Once the data began to be digitized, the possibility of using that data to uncover new
insights about diseases and managing
patients more proactively and precisely became
possible. The past decade has seen the launch of many companies the digital health space and there has been key learnings from the successes
and failures of these products and companies.
Most recently, with the advancement of the big
data and analytics capabilities and the re-emergence of AI, there is intense focus in the application of AI in healthcare. This is due
to the increased availability of big data, increased computing power, and more sophisticated analytic capabilities. There is now more
than a decade of EHR data and increasingly, the data from radiology, pathology, ophthalmology, among others, is digitized. This opens
up a world of possibilities for using AI in discovering, developing, and delivering the next generation of diagnostics and therapeutics.
The last few years has seen the FDA approvals of the first wave of AI solutions in medicine. Applications in radiology and pathology show
that ML algorithms can be used to accelerate diagnosis, complement human judgement and subjectivity, and provide consistency across individuals
and institutions. Drug discovery and development, one of the most promising applications of AI in medicine, is seeing significant early
interest from the public sector and pharma companies.
There are significant issues in healthcare that
give rise to the opportunities for AI: large number of serious diagnostic errors, mistakes in treatment, waste of resources, inefficiencies
in workflows, and more. AI in medicine market is seeing explosive growth. In 2018, the market for AI in medicine was at ~$2B, mostly in
computer aided diagnosis in mammograms. This is projected to increase by 18 folds by 2025 to $36B. Most of this projected growth is expected
to be due to diagnostics such as applications in radiology and pathology. In radiology, drivers of growth will be soft tissue imaging
such as MRI and CT scans. Some of the top projected applications will include robot-assisted surgery, virtual nursing assistants, dosage
error reduction, automated image diagnosis, preliminary diagnosis, clinical trial participant identifier, and more.
In private market funding, healthcare AI start-ups
have raised over $6B across more than 700 deals since 2013, topping all other industries in AI deal activity. So far, diagnostics has
been a major driver of health AI deals. The more streamlined and faster FDA approval process for medical algorithms has meant new commercial
pathways for over 100 AI imaging & diagnostics companies that have raised equity financing since 2013, accounting for a total of close
to 200 deals. These companies span a number of potential promising areas for AI in medicine but Development of new treatments, population
health, and workflow automation are considered the most promising applications. A review of the vast array of potential value propositions
being funded reveal that investors believe that AI/ML has the potential to disrupt all aspects of healthcare business and delivery.
Although many algorithms are being created,
only a small fraction will ever be widely commercialized due to the many barriers at various stages. These include algorithms that do
not perform as expected in the real clinical environment, where the clinical cases encountered many be more diverse than the data used
to train the algorithm; incompatibility with the entire clinical workflow; inability to reproduce the results by other investigators and
clinicians; lack of supporting data from large-scale clinical trials analogous to the ones used for drugs and medical devices; and the
lack of existing infrastructure in health systems to install these algorithms. It is increasingly clear that solving for these barriers
and clinical use cases will be the differentiator between companies that succeed in achieving commercial success and those that fail to
gain traction in spite of strong use cases or innovative solutions.
Given the complexity of the healthcare sector
and the many factors that can lead to the success or failure of any new solutions, and especially in an emerging field such as AI in medicine,
the next few years will present huge opportunities for knowledgeable investors and operators to fund and develop companies that can navigate
this challenging landscape. Our team includes members who have developed and commercialized some of the most innovative solutions in digital
health over the past decade and have deep knowledge and expertise in the barriers that prevent well-conceived solutions from ever achieving
their promise. They have also been advising medical centers and life science companies in evaluating and adopting big data solutions in
digital and AI and understand the needs of these stakeholders and their complex internal workflows and challenges.
Competitive Differentiation
We intend to capitalize on the mentioned deep
expertise and experience of our team to identify, acquire, and operate companies in the AI in Medicine space. Given the enormous opportunity
and the exponential growth ahead coupled with the complexity of identifying the promising solutions that can actually gain clinical adoption,
our team will be able to deliver significant risk-adjusted returns for our investors.
|
• |
|
Industry expertise: diverse background of our team members includes deep clinical expertise as practicing physicians, life sciences consulting experience at McKinsey, Founders and CEOs of digital health companies, investors in healthcare and biopharma and experience in corporate transactions such as equity fundraising, M&A, and IPOs. |
|
• |
|
Strong network: the diverse background of our team and their many years in the different areas in healthcare, including experience as clinicians at the highest level of clinical medicine at institutions such as the Mayo Clinic and with the top life science companies as McKinsey consultants, and investors in high-impact companies, means that sourcing companies and finding great talent for them, and helping them with connecting to the right clinical institutions will be a major source of competitive advantage. |
|
|
|
|
|
• |
|
Deal experience: members of our team has been involved in some of the largest equity and M&A deals in healthcare and digital health over the last two decades, including the Pfizer acquisition of Wyeth pharmaceuticals, equity financing of digital health companies such as Castlight health and Acupera, and exists of companies such as Flatiron health. |
|
|
|
|
|
• |
|
Operational value-add: given the experience of the team in commercializing digital solutions in healthcare, there will be significant lessons learned that can be used in ensuring product-market fit and faster adoption. This will also include a network of medical centers that can be used to generate evidence for the solutions that will eventually be the major driver for the adoption of such solutions. |
This narrow focus in AI in Medicine, one of
the most promising fields in healthcare, already experiencing explosive growth, coupled with the complexity of achieving commercial success
in this space, means that our team’s background and experience can be a source of great differentiation and value creation for our
investors.
Acquisition Criteria
A methodical and disciplined approach will
be used to identify and evaluate potential acquisition targets. This score-card based approach will be heavily informed by our experience
in developing and commercializing digital health products.
|
• |
|
Sector focus: although AI in Medicine will touch almost every aspect of healthcare, the short- and medium-term applications that will yield significant growth and ROI will be in certain sectors that have certain characteristics. These include the presence of large amounts of structured data, current diagnostic or therapeutic challenges, current solutions with significant limitations, and available infrastructure and workflows to launch the solutions. |
|
|
|
|
|
• |
|
Nature of products and solutions: experience to date in AI in Medicine shows that successfully developed algorithms with FDA approval have struggled to gain traction in clinical medicine due to a number of factors. These include the urgency of the issues they are tackling, complexity of their incorporation into the clinical workflows, reimbursement issues by payers, impact on medical center revenues and profits, and more. This vast experience with what it takes to reach clinical adoption and commercial success will guide our selection of potential targets. |
|
|
|
|
|
• |
|
Opportunities for accelerating growth: innovative companies with algorithms in radiology, dermatology, pathology, drug discovery and so forth are encountering various barriers for the adoption of their solutions. Examination of the leadership of these companies shows great technical and product expertise but limited clinical experience or lack of familiarity with the process of generating evidence that leads to clinical adoption and insurance reimbursement. Given the depth and diversity of the experience in our team, we will look for innovative companies that have products that can gain clinical adoption and reimbursement if the right evidence is generated with a network of clinical partners. |
|
|
|
|
|
• |
|
Strong management teams: given the complexity of healthcare and the blend of expertise that will be needed to develop strong products and incorporate them into the clinical workflows, we will look for teams that have a strong track record of developing products, strong data science expertise, digital application experience, with clinical experience preferred by not absolutely necessary as our team will be able to round out their data and digital experience with expertise in clinical and digital health, as well as commercial and corporate finance experience. |
These criteria are not exhaustive and we will
consider these along with other key criteria as we embark on the journey to identify and evaluate companies. There will be company-specific
criteria that will emerge as we examine the products and business models of the companies in AI in Medicine. Given the deep and diverse
experience of our team, we will be able to discern the product- and company-specific criteria of success and determine the company’s
strengths and weaknesses against those criterial and in the case of weaknesses, how our team can be a catalyst in overcoming those weaknesses.
Initial Business Combination
Nasdaq rules require that we must complete one
or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account
(excluding taxes payable on the interest earned on the trust account) at the time of our signing a definitive agreement in connection
with our initial business combination. Our board of directors will make the determination as to the fair market value of our initial business
combination. If our board of directors is not able to independently determine the fair market value of our initial business combination,
we will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm with
respect to the satisfaction of such criteria. While we consider it unlikely that our board of directors will not be able to make an independent
determination of the fair market value of our initial business combination, it may be unable to do so if it is less familiar or experienced
with the business of a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets
or prospects. Additionally, pursuant to Nasdaq rules, any initial business combination must be approved by a majority of our independent
directors.
We anticipate structuring our initial business
combination either (i) in such a way so that the post-transaction company in which our public stockholders own shares will own or
acquire 100% of the equity interests or assets of the target business or businesses, or (ii) in such a way so that the post-transaction
company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the
target management team or stockholders, or for other reasons. However, we will only complete an initial business combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in
the target sufficient for it not to be required to register as an investment company under the Investment Company Act. Even if the post-transaction
company owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the initial business combination
may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the
initial business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange
for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However,
as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to our initial business combination
could own less than a majority of our outstanding shares subsequent to our initial business combination.
If less than 100% of the equity interests or
assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses
that is owned or acquired is what will be taken into account for purposes of Nasdaq’s 80% of net assets test. If the initial business
combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the transactions
and we will treat the target businesses together as the initial business combination for purposes of a tender offer or for seeking stockholder
approval, as applicable.
Our Business Combination Process
In evaluating prospective business combinations,
we expect to conduct a thorough due diligence review process that will encompass, among other things, a review of historical and projected
financial and operating data, meetings with management and their advisors (if applicable), on-site inspection of facilities and assets,
discussion with customers and suppliers, legal reviews and other reviews as we deem appropriate.
We are not prohibited from pursuing an initial
business combination with a company that is affiliated with our sponsor or our officers or directors. In the event we seek to complete
our initial business combination with a company that is affiliated with our sponsor, officers or directors, we, or a committee of independent
directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting
firm that our initial business combination is fair to our company from a financial point of view.
We will issue to our officers and our directors
an aggregate of 300,000 post business combination shares within 10 days following the business combination, with the same lock-up restrictions
and registration rights as the founder shares. Because of this arrangement, our sponsor and our officers and directors may have a conflict
of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business
combination. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business
combination if the retention or resignation of any such officers and directors were to be included by a target business as a condition
to any agreement with respect to our initial business combination.
We have not selected any specific business combination
target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business
combination target.
Each of our officers and directors presently
has, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such
officer or director is or will be required to present a business combination opportunity. Accordingly, if any of our officers or directors
becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual
obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We believe,
however, that the fiduciary duties or contractual obligations of our officers or directors will not materially affect our ability to complete
our initial business combination. Our amended and restated certificate of incorporation provides that we renounce our interest in any
corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or
her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake
and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to
us without violating another legal obligation.
Our Management Team
Members of our management team are not obligated
to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs
until we have completed our initial business combination. The amount of time that any member of our management team will devote in any
time period will vary based on whether a target business has been selected for our initial business combination and the current stage
of the business combination process.
We believe our management team’s operating
and transaction experience and relationships with companies will provide us with a substantial number of potential business combination
targets. Over the course of their careers, the members of our management team have developed a broad network of contacts and corporate
relationships in various industries. This network has grown through the activities of our management team sourcing, acquiring and financing
businesses, our management team’s relationships with sellers, financing sources and target management teams and the experience of
our management team in executing transactions under varying economic and financial market conditions. See the section of this Annual Report
entitled “Management” for a more complete description of our management team’s experience.
Status as a Public Company
We believe our structure will make us an attractive
business combination partner to target businesses. As a public company, we offer a target business an alternative to the traditional initial
public offering through a merger or other business combination with us. Following an initial business combination, we believe the target
business would have greater access to capital and additional means of creating management incentives that are better aligned with stockholders’
interests than it would as a private company. A target business can further benefit by augmenting its profile among potential new customers
and vendors and aid in attracting talented employees. In a business combination transaction with us, the owners of the target business
may, for example, exchange their shares of stock in the target business for our shares of Class A common stock (or shares of a new
holding company) or for a combination of our shares of Class A common stock and cash, allowing us to tailor the consideration to
the specific needs of the sellers.
Although there are various costs and obligations
associated with being a public company, we believe target businesses will find this method a more expeditious and cost effective method
to becoming a public company than the typical initial public offering. The typical initial public offering process takes a significantly
longer period of time than the typical business combination transaction process, and there are significant expenses in the initial public
offering process, including underwriting discounts and commissions, marketing and road show efforts that may not be present to the same
extent in connection with an initial business combination with us.
Furthermore, once a proposed initial business
combination is completed, the target business will have effectively become public, whereas an initial public offering is always subject
to the underwriters’ ability to complete the offering, as well as general market conditions, which could delay or prevent the offering
from occurring or could have negative valuation consequences. Following an initial business combination, we believe the target business
would then have greater access to capital and an additional means of providing management incentives consistent with stockholders’
interests and the ability to use its shares as currency for acquisitions. Being a public company can offer further benefits by augmenting
a company’s profile among potential new customers and vendors and aid in attracting talented employees.
While we believe that our structure and our
management team’s backgrounds will make us an attractive business partner, some potential target businesses may view our status
as a blank check company, such as our lack of an operating history and our ability to seek stockholder approval of any proposed initial
business combination, negatively.
We are an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies”
including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result,
there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of the JOBS Act
also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B)
of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company”
can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to
take advantage of the benefits of this extended transition period.
We will remain an emerging growth company until
the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the IPO, (b) in
which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer,
which means the market value of our Class A common stock that is held by non-affiliates exceeds $700 million as of the prior September
30, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year
period.
Additionally, we are a “smaller reporting
company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting
company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates exceeds $250
million as of the end of the prior September 30, or (2) our annual revenues exceeded $100 million during such completed fiscal year
and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior September 30.
Offering Structure
Unlike other blank check companies that sell
units comprised of shares of common stock and warrants to purchase a full share of common stock in their initial public offerings, we
are selling units, each unit comprised of one share of Class A common stock and one right which entitles the holder thereof to receive
one-tenth (1/10) of one share of Class A common stock upon consummation of our initial business combination. Our management believes that
investors in similarly structured blank check offerings, and those likely to invest in the IPO, have come to expect the units of such
companies to include one share of common stock and another security which would allow the holders to acquire additional shares of common
stock. Without the ability to acquire such additional shares of common stock, our management believes the investors would not be willing
to purchase units in such companies’ initial public offerings. Accordingly, because the number of shares ordinarily issuable upon
exercise of the warrants found in the structure of other blank check initial public offerings is lessened in our case (since units often
consist of a whole warrant that entitles the holder thereof to receive a full share of common stock as opposed to the one-tenth (1/10)
of one share the rights entitle a holder to receive), our management believes we may be viewed more favorably by potential target companies
when determining which company to engage in a business combination with. However, our management may be incorrect in this belief.
Financial Position
With funds available for an initial business
combination initially in the amount of $123,337,500 assuming no redemptions, after payment of $4,427,500 of Marketing Fee payable to I-Bankers,
in each case before fees and expenses associated with our initial business combination, together with the Marketing Fee, we offer
a target business a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and
expansion of its operations or strengthening its balance sheet by reducing its debt or leverage ratio. Because we are able to complete
our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility
to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs
and desires. However, we have not taken any steps to secure third party financing and there can be no assurance it will be available to
us.
Effecting Our Initial Business Combination
We are not presently engaged in, and we will
not engage in, any operations for an indefinite period of time following the IPO. We intend to effectuate our initial business combination
using cash from the proceeds of the IPO and the private placement of the private placement units, the proceeds of the sale of our shares
in connection with our initial business combination (including pursuant to forward purchase agreements or backstop agreements we may enter
into following the consummation of the IPO or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders
or the owners of the target, or a combination of the foregoing. We may seek to complete our initial business combination with a company
or business that may be financially unstable or in its early stages of development or growth, which would subject us to the numerous risks
inherent in such companies and businesses.
If our initial business combination is paid
for using equity or debt securities, or not all of the funds released from the trust account are used for payment of the consideration
in connection with our initial business combination or used for redemptions of our Class A common stock, we may apply the balance
of the cash released to us from the trust account for general corporate purposes, including for maintenance or expansion of operations
of the post-transaction company, the payment of principal or interest due on indebtedness incurred in completing our initial business
combination, to fund the purchase of other companies or for working capital.
We may seek to raise additional funds through
a private offering of debt or equity securities in connection with the completion of our initial business combination, and we may effectuate
our initial business combination using the proceeds of such offering rather than using the amounts held in the trust account. In addition,
we intend to target businesses larger than we could acquire with the net proceeds of the IPO and the sale of the private placement units,
and may as a result be required to seek additional financing to complete such proposed initial business combination. Subject to compliance
with applicable securities laws, we would expect to complete such financing only simultaneously with the completion of our initial business
combination. In the case of an initial business combination funded with assets other than the trust account assets, our proxy materials
or tender offer documents disclosing the initial business combination would disclose the terms of the financing and, only if required
by law, we would seek stockholder approval of such financing. There are no prohibitions on our ability to raise funds privately, or through
loans in connection with our initial business combination. At this time, we are not a party to any arrangement or understanding with any
third party with respect to raising any additional funds through the sale of securities or otherwise.
Sources of Target Businesses
We anticipate that target business candidates
will be brought to our attention from various unaffiliated sources, including investment bankers and investment professionals. Target
businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us by calls or mailings. These
sources may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since many of these
sources will have read this Annual Report and know what types of businesses we are targeting. Our officers and directors, as well as our
sponsor and their affiliates, may also bring to our attention target business candidates that they become aware of through their business
contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In
addition, we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us
as a result of the business relationships of our officers and directors and our sponsor and their affiliates. While we do not presently
anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis,
we may engage these firms or other individuals in the future, in which event we may pay a finder’s fee, consulting fee, advisory
fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction. We will engage
a finder only to the extent our management determines that the use of a finder may bring opportunities to us that may not otherwise be
available to us or if finders approach us on an unsolicited basis with a potential transaction that our management determines is in our
best interest to pursue. Payment of finder’s fees is customarily tied to completion of a transaction, in which case any such fee
will be paid out of the funds held in the trust account. In no event, however, will our sponsor or any of our existing officers or directors,
or any entity with which our sponsor or officers are affiliated, be paid any finder’s fee, reimbursement, consulting fee, monies
in respect of any payment of a loan or other compensation by the company prior to, or in connection with any services rendered for any
services they render in order to effectuate, the completion of our initial business combination (regardless of the type of transaction
that it is). None of our sponsor, executive officers or directors, or any of their respective affiliates, will be allowed to receive any
compensation, finder’s fees or consulting fees from a prospective business combination target in connection with a contemplated
initial business combination prior to the business combination. However, we will issue to our officers and directors an aggregate of 300,000
post business combination shares, with the same lock-up restrictions and registration rights as the founder shares. Some of our officers
and directors may enter into employment or consulting agreements with
the post-transaction company following our
initial business combination. The presence or absence of any such fees or arrangements will not be used as a criterion in our selection
process of an initial business combination candidate.
We are not prohibited from pursuing an initial
business combination with an initial business combination target that is affiliated with our sponsor, officers or directors or making
the initial business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors. In
the event we seek to complete our initial business combination with an initial business combination target that is affiliated with our
sponsor, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking
firm which is a member of FINRA or an independent accounting firm that such an initial business combination is fair to our company from
a financial point of view. We are not required to obtain such an opinion in any other context.
As more fully discussed in the section of this
Annual Report entitled “Management — Conflicts of Interest,” if any of our officers or directors becomes aware
of an initial business combination opportunity that falls within the line of business of any entity to which he or she has pre-existing
fiduciary or contractual obligations, he or she may be required to present such business combination opportunity to such entity prior
to presenting such business combination opportunity to us. Our officers and directors currently have certain relevant fiduciary duties
or contractual obligations that may take priority over their duties to us.
Selection of a Target Business and Structuring
of our Initial Business Combination
Nasdaq rules require that we must complete
one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account
(excluding taxes payable on the interest earned on the trust account) at the time of our signing a definitive agreement in connection
with our initial business combination. The fair market value of our initial business combination will be determined by our board of directors
based upon one or more standards generally accepted by the financial community, such as discounted cash flow valuation, a valuation based
on trading multiples of comparable public businesses or a valuation based on the financial metrics of M&A transactions of comparable
businesses. If our board of directors is not able to independently determine the fair market value of our initial business combination,
we will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm with
respect to the satisfaction of such criteria. While we consider it unlikely that our board of directors will not be able to make an independent
determination of the fair market value of our initial business combination, it may be unable to do so if it is less familiar or experienced
with the business of a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets
or prospects. We do not intend to purchase multiple businesses in unrelated industries in conjunction with our initial business combination.
Subject to this requirement, our management will have virtually unrestricted flexibility in identifying and selecting one or more prospective
target businesses, although we will not be permitted to effectuate our initial business combination with another blank check company or
a similar company with nominal operations.
In any case, we will only complete an initial
business combination in which we own or acquire 50% or more of the outstanding voting securities of the target or otherwise acquire a
controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company
Act. If we own or acquire less than 100% of the equity interests or assets of a target business or businesses, the portion of such business
or businesses that are owned or acquired by the post-transaction company is what will be taken into account for purposes of Nasdaq’s
80% of net assets test. There is no basis for investors in the IPO to evaluate the possible merits or risks of any target business with
which we may ultimately complete our initial business combination.
To the extent we effect our initial business
combination with a company or business that may be financially unstable or in its early stages of development or growth we may be affected
by numerous risks inherent in such company or business. Although our management will endeavor to evaluate the risks inherent in a particular
target business, we cannot assure you that we will properly ascertain or assess all significant risk factors.
In evaluating a prospective business target,
we expect to conduct a thorough due diligence review, which may encompass, among other things, meetings with incumbent management and
employees, document reviews, interviews of customers and suppliers, inspection of facilities, as well as a review of financial and other
information that will be made available to us.
The time required to select and evaluate a target
business and to structure and complete our initial business combination, and the costs associated with this process, are not currently
ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target
business with which our initial business combination is not ultimately completed will result in our incurring losses and will reduce the
funds we can use to complete another business combination.
Lack of Business Diversification
For an indefinite period of time after the
completion of our initial business combination, the prospects for our success may depend entirely on the future performance of a single
business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or several industries,
it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business.
In addition, we intend to focus our search for an initial business combination in a single industry. By completing our initial business
combination with only a single entity, our lack of diversification may:
|
• |
|
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and |
|
|
|
|
|
• |
|
cause us to depend on the marketing and sale of a single product or limited number of products or services. |
Limited Ability to Evaluate the Target’s
Management Team
Although we intend to closely scrutinize the
management of a prospective target business when evaluating the desirability of effecting our initial business combination with that business,
our assessment of the target business’ management may not prove to be correct. In addition, the future management may not have the
necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team,
if any, in the target business cannot presently be stated with any certainty. The determination as to whether any of the members
of our management team will remain with the combined company will be made at the time of our initial business combination. While it is
possible that one or more of our directors will remain associated in some capacity with us following our initial business combination,
it is unlikely that any of them will devote their full efforts to our affairs subsequent to our initial business combination. Moreover,
we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the
particular target business.
We cannot assure you that any of our key personnel
will remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel
will remain with the combined company will be made at the time of our initial business combination.
Following an initial business combination, we
may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we will
have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary
to enhance the incumbent management.
Stockholders May Not Have the Ability to
Approve Our Initial Business Combination
We may conduct redemptions without a stockholder
vote pursuant to the tender offer rules of the SEC. However, we will seek stockholder approval if it is required by law or applicable
stock exchange rule, or we may decide to seek stockholder approval for business or other legal reasons. Presented in the table below is
a graphic explanation of the types of initial business combinations we may consider and whether stockholder approval is currently required
under Delaware law for each such transaction.
Type of Transaction |
|
Whether Stockholder Approval is
Required |
Purchase of assets |
|
No |
Purchase of stock of target not involving a merger with the company |
|
No |
Merger of target into a subsidiary of the company |
|
No |
Merger of the company with a target |
|
Yes |
Under Nasdaq’s listing rules, stockholder
approval would be required for our initial business combination if, for example:
|
• |
|
we issue shares of Class A common stock that will be equal to or in excess of 20% of the number of shares of our Class A common stock then outstanding; |
|
• |
|
any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in outstanding common shares or voting power of 5% or more; or |
|
|
|
|
|
• |
|
the issuance or potential issuance of common stock will result in our undergoing a change of control. |
Permitted Purchases of our Securities
If we seek stockholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our initial stockholders, directors, officers, advisors or their affiliates may purchase shares or rights in privately negotiated
transactions or in the open market either prior to or following the completion of our initial business combination. There is no limit
on the number of shares our initial stockholders, directors, officers, advisors or their affiliates may purchase in such transactions,
subject to compliance with applicable law and Nasdaq rules. However, they have no current commitments, plans or intentions to engage
in such transactions and have not formulated any terms or conditions for any such transactions. If they engage in such transactions,
they will not make any such purchases when they are in possession of any material nonpublic information not disclosed to the seller or
if such purchases are prohibited by Regulation M under the Exchange Act. We do not currently anticipate that such purchases, if any,
would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the
going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases
are subject to such rules, the purchasers will comply with such rules. Any such purchases will be reported pursuant to Section 13
and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. None of the funds held
in the trust account will be used to purchase shares or rights in such transactions prior to completion of our initial business combination.
The purpose of any such purchases of shares
could be to vote such shares in favor of the initial business combination and thereby increase the likelihood of obtaining stockholder
approval of the initial business combination or to satisfy a closing condition in an agreement with a target that requires us to have
a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement
would otherwise not be met. The purpose of any such purchases of rights could be to reduce the number of rights, or underlying shares,
outstanding. Any such purchases of our securities may result in the completion of our initial business combination that may not otherwise
have been possible. In addition, if such purchases are made, the public “float” of our shares of Class A common stock
or rights may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain
or obtain the quotation, listing or trading of our securities on a national securities exchange.
Our sponsor, officers, directors and/or their
affiliates anticipate that they may identify the stockholders with whom our sponsor, officers, directors or their affiliates may pursue
privately negotiated purchases by either the stockholders contacting us directly or by our receipt of redemption requests submitted by
stockholders following our mailing of proxy materials in connection with our initial business combination. To the extent that our sponsor,
officers, directors, or their affiliates enter into a private purchase, they would identify and contact only potential selling stockholders
who have expressed their election to redeem their shares for a pro rata share of the trust account or vote against our initial business
combination, whether or not such stockholder has already submitted a proxy with respect to our initial business combination. Our sponsor,
officers, directors, advisors or their affiliates will only purchase shares if such purchases comply with Regulation M under the Exchange
Act and the other federal securities laws.
Any purchases by our sponsor, officers, directors
and/or their affiliates who are affiliated purchasers under Rule 10b-18 under the Exchange Act will only be made to the extent such
purchases are able to be made in compliance with Rule 10b-18, which is a safe harbor from liability for manipulation under Section 9(a)(2)
and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain technical requirements that must be complied with in order for the
safe harbor to be available to the purchaser. Our sponsor, officers, directors and/or their affiliates will not make purchases of common
stock if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act. Any such purchases will be reported
pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchases are subject to such reporting requirements.
Redemption Rights for Public Stockholders
upon Completion of our Initial Business Combination
We will provide our public stockholders with
the opportunity to redeem all or a portion of their shares of Class A common stock upon the completion of our initial business combination
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior
to the consummation of the initial business
combination including interest earned on the
funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then
outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be
approximately $10.10 per public share. Our initial stockholders, officers and directors and I-Bankers have entered into a letter agreement
with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares, private placement shares,
representative shares and any public shares held by them in connection with the completion of our initial business combination.
Manner of Conducting Redemptions
We will provide our public stockholders with
the opportunity to redeem all or a portion of their shares of Class A common stock upon the completion of our initial business combination
either (i) in connection with a stockholder meeting called to approve the initial business combination or (ii) by means of a
tender offer. The decision as to whether we will seek stockholder approval of a proposed initial business combination or conduct a tender
offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and
whether the terms of the transaction would require us to seek stockholder approval under the law or stock exchange listing requirement.
Under Nasdaq rules, asset acquisitions and stock purchases would not typically require stockholder approval while direct mergers with
our company where we do not survive and any transactions where we issue more than 20% of our outstanding common stock or seek to amend
our amended and restated certificate of incorporation would require stockholder approval. If we structure an initial business combination
with a target company in a manner that requires stockholder approval, we will not have discretion as to whether to seek a stockholder
vote to approve the proposed initial business combination. We may conduct redemptions without a stockholder vote pursuant to the tender
offer rules of the SEC unless stockholder approval is required by law or stock exchange listing requirements or we choose to seek stockholder
approval for business or other legal reasons. So long as we obtain and maintain a listing for our securities on Nasdaq, we will be required
to comply with such rules.
If a stockholder vote is not required and
we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our amended and restated certificate
of incorporation:
|
• |
|
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and |
|
|
|
|
|
• |
|
file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
Upon the public announcement of our initial
business combination, we or our sponsor will terminate any plan established in accordance with Rule 10b5-1 to purchase shares of
our Class A common stock in the open market if we elect to redeem our public shares through a tender offer, to comply with Rule 14e-5
under the Exchange Act.
In the event we conduct redemptions pursuant
to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under
the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer period.
In addition, the tender offer will be conditioned on public stockholders not tendering more than a specified number of public shares which
are not purchased by our sponsor, which number will be based on the requirement that we will only redeem our public shares so long as
(after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial
business combination and after payment of underwriters’ fees and commissions (so that we are not subject to the SEC’s “penny
stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial
business combination. If public stockholders tender more shares than we have offered to purchase, we will withdraw the tender offer and
not complete the initial business combination.
If, however, stockholder approval of the transaction
is required by law or stock exchange listing requirement, or we decide to obtain stockholder approval for business or other legal reasons,
we will, pursuant to our amended and restated certificate of incorporation:
|
• |
|
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and |
|
|
|
|
|
• |
|
file proxy materials with the SEC. |
In the event that we seek stockholder approval
of our initial business combination, we will distribute proxy materials and, in connection therewith, provide our public stockholders
with the redemption rights described above upon completion of the initial business combination.
If we seek stockholder approval, we will complete
our initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the initial
business combination. A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital
stock of the company representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to
vote at such meeting. Our initial stockholders will count toward this quorum and pursuant to the letter agreement, our initial stockholders,
officers and directors and I-Bankers have agreed to vote their founder shares, private placement shares, representative shares and any
public shares purchased during or after the IPO (including in open market and privately negotiated transactions) in favor of our initial
business combination. For purposes of seeking approval of the majority of our outstanding shares of common stock voted, non-votes will
have no effect on the approval of our initial business combination once a quorum is obtained. As a result, in addition to founder shares,
private placement shares and representative shares, we would need only 4,433,401 shares, or 35.0%, of the 12,650,000 public shares sold
in the IPO to be voted in favor of an initial business combination (assuming all outstanding shares are voted), or 325,101 shares, or
2.6%, the 12,650,000 public shares sold in the IPO to be voted in favor of an initial business combination (assuming only a quorum is
present), in order to have our initial business combination approved. We intend to give approximately 30 days (but not less than
10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall be taken to approve
our initial business combination. These quorum and voting thresholds, and the voting agreements of our initial stockholders, may make
it more likely that we will consummate our initial business combination. Each public stockholder may elect to redeem its public shares
irrespective of whether they vote for or against the proposed transaction.
Our amended and restated certificate of incorporation
provides that we will only redeem our public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001
either immediately prior to or upon consummation of our initial business combination and after payment of underwriters’ fees and
commissions (so that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash
requirement which may be contained in the agreement relating to our initial business combination. For example, the proposed initial business
combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred to the
target for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions in accordance
with the terms of the proposed initial business combination. In the event the aggregate cash consideration we would be required to pay
for all shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete
the initial business combination or redeem any shares, and all shares of Class A common stock submitted for redemption will be returned
to the holders thereof.
Limitation on Redemption upon Completion
of our Initial Business Combination if we Seek Stockholder Approval
Notwithstanding the foregoing, if we seek stockholder
approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant
to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any
affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined
under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of
15% of the shares sold in the IPO, which we refer to as the “Excess Shares.” Such restriction shall also be applicable to
our affiliates. We believe this restriction will discourage stockholders from accumulating large blocks of shares, and subsequent attempts
by such holders to use their ability to exercise their redemption rights against a proposed initial business combination as a means to
force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable
terms. Absent this provision, a public stockholder holding more than an aggregate of 15% of the shares sold in the IPO could threaten
to exercise its redemption rights if such holder’s shares are not purchased by us or our management at a premium to the then-current
market price or on other undesirable terms. By limiting our stockholders’ ability to redeem no more than 15% of the shares sold
in the IPO without our prior consent, we believe we will limit the ability of a small group of stockholders to unreasonably attempt to
block our ability to complete our initial business combination, particularly in connection with an initial business combination with a
target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. However, we would not be restricting
our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination.
Tendering Stock Certificates in Connection
with a Tender Offer or Redemption Rights
We may require our public stockholders seeking
to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to either tender
their certificates to our transfer agent prior to the date set forth in the tender offer documents or proxy materials mailed to such holders,
or up to two business days prior to the vote on the proposal to approve the initial business combination in the event we distribute proxy
materials, or to deliver their shares to the transfer agent electronically using the Depository Trust Company’s DWAC (Deposit/Withdrawal
At Custodian) System, at the holder’s option. The tender offer or proxy materials, as applicable, that we will furnish to holders
of our public shares in connection with our initial business combination will indicate whether we are requiring public stockholders to
satisfy such delivery requirements. Accordingly, a public stockholder would have from the time we send out our tender offer materials
until the close of the tender offer period, or up to two days prior to the vote on the initial business combination if we distribute proxy
materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights. Given the relatively short exercise
period, it is advisable for stockholders to use electronic delivery of their public shares.
There is a nominal cost associated with the
above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent
will typically charge the tendering broker $80.00 and it would be up to the broker whether or not to pass this cost on to the redeeming
holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender
their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery
must be effectuated.
The foregoing is different from the procedures
used by many blank check companies. In order to perfect redemption rights in connection with their business combinations, many blank check
companies would distribute proxy materials for the stockholders’ vote on an initial business combination, and a holder could simply
vote against a proposed initial business combination and check a box on the proxy card indicating such holder was seeking to exercise
his or her redemption rights. After the initial business combination was approved, the company would contact such stockholder to arrange
for him or her to deliver his or her certificate to verify ownership. As a result, the stockholder then had an “option window”
after the completion of the initial business combination during which he or she could monitor the price of the company’s stock in
the market. If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering
his or her shares to the company for cancellation. As a result, the redemption rights, to which stockholders were aware they needed to
commit before the stockholder meeting, would become “option” rights surviving past the completion of the initial business
combination until the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting
ensures that a redeeming holder’s election to redeem is irrevocable once the initial business combination is approved.
Any request to redeem such shares, once made,
may be withdrawn at any time up to the date set forth in the tender offer materials or the date of the stockholder meeting set forth in
our proxy materials, as applicable. Furthermore, if a holder of a public share delivered its certificate in connection with an election
of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder may simply
request that the transfer agent return the certificate (physically or electronically). It is anticipated that the funds to be distributed
to holders of our public shares electing to redeem their shares will be distributed promptly after the completion of our initial business
combination.
If our initial business combination is not
approved or completed for any reason, then our public stockholders who elected to exercise their redemption rights would not be entitled
to redeem their shares for the applicable pro rata share of the trust account. In such case, we will promptly return any certificates
delivered by public holders who elected to redeem their shares.If our initial
proposed initial business combination is not completed, we may continue to try to complete an initial business combination with a different
target until 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time to
consummate a business combination, as described in more detail in this Annual Report).
Ability to Extend Time to Complete Business
Combination
We will have until 12 months from the closing
of the IPO to consummate an initial business combination. However, if we anticipate that we may not be able to consummate our initial
business combination within 12 months, we may extend the period of time to consummate a business combination up to two times, each by
an additional three months (for a total of up to 18 months to complete a business combination). Pursuant to the terms of our amended and
restated certificate of incorporation and the trust agreement entered into between us and American Stock Transfer & Trust Company
on October 26, 2021, in order to extend the time available for us to consummate our initial business combination, our sponsor or its affiliates
or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account up
to $1,265,000 ($0.10 per share) on or prior
to the date of the applicable deadline, for each three month extension (or up to an aggregate of $2,530,000, or $0.20 per share, if we
extend for the full six months). In the event that we receive notice from our sponsor five days prior to the applicable deadline of their
intent to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the applicable
deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the funds had
been timely deposited. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for
us to complete our initial business combination.
Redemption of Public Shares and Liquidation
if no Initial Business Combination
Our amended and restated certificate of incorporation
provides that we will have only 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the
period of time to consummate a business combination, as described in more detail in this Annual Report) to complete our initial business
combination. If we are unable to complete our initial business combination within such 12-month period (or up to 18-month period), we
will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than
ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our franchise
and income taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption
rights or liquidating distributions with respect to our rights, which will expire worthless if we fail to complete our initial business
combination within the 12-month time period (or up to 18-month period).
Our initial stockholders, officers and directors
and I-Bankers have entered into a letter agreement with us, pursuant to which they have waived their rights to liquidating distributions
from the trust account with respect to any founder shares, private placement shares or representative shares held by them if we fail to
complete our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO
if we extend the period of time to consummate a business combination, as described in more detail in this Annual Report). However, if
our initial stockholders officers or directors acquire public shares in or after the IPO, they will be entitled to liquidating distributions
from the trust account with respect to such public shares if we fail to complete our initial business combination within the allotted
12-month time period (or up to 18-month period).
Our initial stockholders, officers and directors
have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our amended and restated certificate
of incorporation (i) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend
the period of time to consummate a business combination, as described in more detail in this Annual Report) or (ii) with respect
to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless we provide our public
stockholders with the opportunity to redeem their shares of Class A common stock upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held
in the trust account and not previously released to us to pay our franchise and income taxes divided by the number of then outstanding
public shares. However, we will only redeem our public shares so long as (after such redemption) our net tangible assets will be at least
$5,000,001 either immediately prior to or upon consummation of our initial business combination and after payment of underwriters’
fees and commissions (so that we are not subject to the SEC’s “penny stock” rules). If this optional redemption right
is exercised with respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement (described
above), we would not proceed with the amendment or the related redemption of our public shares at such time.We
expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts remaining out of the approximately $900,000 of proceeds held outside the trust account, although we cannot assure
you that there will be sufficient funds for such purpose. We will depend on sufficient interest being earned on the proceeds held in the
trust account to pay any franchise and income tax obligations we may owe. However, if those funds are not sufficient to cover the costs
and expenses associated with implementing our plan of dissolution, to the extent that there is any interest accrued in the trust account
not required to pay franchise and income taxes on interest income earned on the trust account balance, we may request the trustee to release
to us an additional amount of up to $50,000 of such accrued interest to pay those costs and expenses.
If we were to expend all of the net proceeds
of the IPO and the sale of the private placement units, other than the proceeds deposited in the trust account, and without taking into
account interest, if any, earned on the trust account, the per-share redemption amount received by stockholders upon our dissolution would
be approximately $10.10. The proceeds deposited in the trust account could, however, become subject to the claims of our creditors which
would have higher priority than the claims of our public stockholders. We cannot assure you that the actual per-share redemption amount
received by stockholders will not be substantially less than $10.10. Under Section 281(b) of the DGCL, our plan of dissolution must
provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient
assets. These claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we
intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’
claims.
Although we will seek to have all vendors, service
providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title,
interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, there is no guarantee
that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against
the trust account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well
as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our
assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies
held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement
with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly
more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a
waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly
superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider
willing to execute a waiver. MaloneBailey, LLP, our independent registered public accounting firm, and the underwriters of the offering,
will not execute agreements with us waiving such claims to the monies held in the trust account.
In addition, there is no guarantee that such
entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or
agreements with us and will not seek recourse against the trust account for any reason. Our sponsor has agreed that it will be liable
to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective target business
with which we have entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce
the amount of funds in the trust account to below the lesser of (i) $10.10 per public share and (ii) the actual amount per public
share held in the trust account as of the date of the liquidation of the trust account, if less than $10.10 per share due to reductions
in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective
target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable)
nor will it apply to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities
under the Securities Act. However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently
verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and believe that our sponsor’s only assets
are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. None of our
officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target
businesses.
In the event that the proceeds in the trust
account are reduced below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as of
the date of the liquidation of the trust account, due to reductions in value of the trust assets, in each case net of the amount of interest
which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its indemnification obligations or that it has
no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against
our sponsor to enforce its indemnification obligations.
While we currently expect that our independent
directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that
our independent directors in exercising their business judgment may choose not to do so if, for example, the cost of such legal action
is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine that
a favorable outcome is not likely. We have not asked our sponsor to reserve for such indemnification obligations and we cannot assure
you that our sponsor would be able to satisfy those obligations. Accordingly, we cannot assure you that due to claims of creditors the
actual value of the per-share redemption price will not be less than $10.10 per public share.
We will seek to reduce the possibility that our sponsor
will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers, prospective
target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of
any kind in or to monies held in the trust account. Our sponsor will also not be liable as to any claims under our indemnity of the underwriters
of the IPO against certain liabilities, including liabilities under the Securities Act. We will have access to up to approximately $500,000
from the proceeds of the IPO with which to pay any such potential claims (including costs and expenses incurred in connection with our
liquidation, currently estimated to be no more than approximately $50,000). In the event that we liquidate and it is subsequently determined
that the reserve for claims and liabilities is insufficient, stockholders who received funds from our trust account could be liable for
claims made by creditors. In the event that our offering expenses exceed our estimate of $500,000, we may fund such excess with funds
from the funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside the trust account would
decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than our estimate of $500,000, the amount
of funds we intend to be held outside the trust account would increase by a corresponding amount.
Under the DGCL, stockholders may be held liable
for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion
of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our
initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend
the period of time to consummate a business combination, as described in more detail in this Annual Report) may be considered a liquidating
distribution under Delaware law.
If the corporation complies with certain procedures
set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a
60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during which the corporation
may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders,
any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata
share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third
anniversary of the dissolution.
Furthermore, if the pro rata portion of our
trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our initial
business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period
of time to consummate a business combination, as described in more detail in this Annual Report), is not considered a liquidating distribution
under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings that
a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the statute
of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as
in the case of a liquidating distribution. If we are unable to complete our initial business combination within 12 months from the closing
of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time to consummate a business combination, as described
in more detail in this Annual Report), we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and
not previously released to us to pay our franchise and income taxes (less up to $50,000 of interest to pay dissolution expenses), divided
by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate,
subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable
law. Accordingly, it is our intention to redeem our public shares as soon as reasonably possible following our 12th month (or
up to 21st month) and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially
be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend
well beyond the third anniversary of such date.
Because we will not be complying with Section 280,
Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment
of all existing and pending claims or claims that may be potentially brought against us within the subsequent 10 years. However,
because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective
target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or
prospective target businesses.
As described above, pursuant to the obligation
contained in our underwriting agreement, we will seek to have all vendors, service providers, prospective target businesses or other entities
with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held
in the trust account.
As a result of this obligation, the claims
that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending
to the trust account is remote. Further, our sponsor may be liable only to the extent necessary to ensure that the amounts in the trust
account are not reduced below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as
of the date of the liquidation of the trust account, due to reductions in value of the trust assets, in each case net of the amount of
interest withdrawn to pay taxes and will not be liable as to any claims under our indemnity of the underwriters of the
IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be
unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims.
If we file a bankruptcy petition or an involuntary
bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy
law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders.
To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to return $10.10 per share to our
public stockholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is
not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either
a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover
some or all amounts received by our stockholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty
to our creditors and/or may have acted in bad faith, thereby exposing itself and our company to claims of punitive damages, by paying
public stockholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought
against us for these reasons.
Our public stockholders will be entitled to
receive funds from the trust account only upon the earlier to occur of: (i) the completion of our initial business combination, (ii) the
redemption of any public shares properly tendered in connection with a stockholder vote to amend any provisions of our amended and restated
certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do
not complete our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the
IPO if we extend the period of time to consummate a business combination, as described in more detail in this Annual Report) or (B) with
respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, and (iii) the
redemption of all of our public shares if we are unable to complete our business combination within 12 months from the closing of the
IPO (or up to 18 months from the closing of the IPO if we extend the period of time to consummate a business combination, as described
in more detail in this Annual Report), subject to applicable law.
In no other circumstances will a stockholder
have any right or interest of any kind to or in the trust account. In the event we seek stockholder approval in connection with our initial
business combination, a stockholder’s voting in connection with the initial business combination alone will not result in a stockholder’s
redeeming its shares to us for an applicable pro rata share of the trust account. Such stockholder must have also exercised its redemption
rights as described above. These provisions of our amended and restated certificate of incorporation, like all provisions of our amended
and restated certificate of incorporation, may be amended with a stockholder vote.
Competition
In identifying, evaluating and selecting a target
business for our initial business combination, we may encounter intense competition from other entities having a business objective similar
to ours, including other blank check companies, private equity groups and leveraged buyout funds, and operating businesses seeking strategic
business combinations. Many of these entities are well established and have extensive experience identifying and effecting business combinations
directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than
we do. Our ability to acquire larger target businesses will be limited by our available financial resources. This inherent limitation
gives others an advantage in pursuing the initial business combination of a target business. Furthermore, our obligation to pay cash in
connection with our public stockholders who exercise their redemption rights may reduce the resources available to us for our initial
business combination, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either
of these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.
Employees
We currently have two officers. These individuals
are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary
to our affairs until we have completed our initial business combination. The amount of time they will devote in any time period will vary
based on whether a target business has been selected for our initial business combination and the stage of the initial business combination
process we are in. We do not intend to have any full time employees prior to the completion of our initial business combination. We
consider the Company’s relations with the Company’s employees to be good.
Periodic Reporting and Financial Information
Class A common stock and rights have been
registered under the Exchange Act and we have reporting obligations under such act, including the requirement that we file annual, quarterly
and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial statements
audited and reported on by our independent registered public accountants.
We will provide stockholders with audited financial
statements of the prospective target business as part of the tender offer materials or proxy solicitation materials sent to stockholders
to assist them in assessing the target business. In all likelihood, these financial statements will need to be prepared in accordance
with, or reconciled to, GAAP, or IFRS, depending on the circumstances, and the historical financial statements may be required to be audited
in accordance with the standards of the PCAOB. These financial statement requirements may limit the pool of potential targets we may conduct
an initial business combination with because some targets may be unable to provide such statements in time for us to disclose such statements
in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame. We cannot assure
you that any particular target business identified by us as a potential business combination candidate will have financial statements
prepared in accordance with GAAP or that the potential target business will be able to prepare its financial statements in accordance
with the requirements outlined above. To the extent that these requirements cannot be met, we may not be able to acquire the proposed
target business. While this may limit the pool of potential business combination candidates, we do not believe that this limitation will
be material.
We will be required to evaluate our internal
control procedures for the fiscal year ending March 31, 2022 as required by the Sarbanes-Oxley Act. Only in the event we are deemed to
be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to have
our internal control procedures audited. A target company may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding
adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley
Act may increase the time and costs necessary to complete any such business combination. We have no current intention of filing a Form 15
to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation of our initial business combination.
We will remain an emerging growth company until
the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the IPO, (b) in
which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer,
which means the market value of our shares of Class A common stock that are held by non-affiliates exceeds $700 million as of the
prior September 30, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year
period.
ITEM 1A. RISK FACTORS
In addition to the other information contained in
this Annual Report on Form 10-K, we have identified the following risks and uncertainties that may have a material adverse effect on the
Company’s business, financial condition or results of operations. You should carefully consider the risks described below before
making an investment decision.
Risks Relating to our Search
for, Consummation of, or Inability to Consummate,
a Business Combination and Post-Business Combination
Risks
We are a newly formed company with no operating
history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
We are a newly formed company with no operating
results, and we will not commence operations until obtaining funding through the IPO. Because we lack an operating history, you have no
basis upon which to evaluate our ability to achieve our
business objective of completing our initial
business combination with one or more target businesses. We have no plans, arrangements or understandings with any prospective target
business concerning an initial business combination and may be unable to complete our initial business combination. If we fail to complete
our initial business combination, we will never generate any operating revenues.
Our public stockholders may not be afforded
an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even
though a majority of our public stockholders do not support such a combination.
We may choose not to hold a stockholder vote
to approve our initial business combination unless the initial business combination would require stockholder approval under applicable
law or stock exchange listing requirements or if we decide to hold a stockholder vote for business or other legal reasons. Except as required
by law, the decision as to whether we will seek stockholder approval of a proposed initial business combination or will allow stockholders
to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors,
such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek stockholder approval.
Accordingly, we may complete our initial business combination even if holders of a majority of our public shares do not approve of the
initial business combination we complete. Please see the section of this Annual Report entitled “Proposed Business — Stockholders
May Not Have the Ability to Approve Our Initial Business Combination” for additional information.
If we seek stockholder approval of our initial
business combination, our initial stockholders have agreed to vote in favor of such initial business combination, regardless of how our
public stockholders vote.
Pursuant to the letter agreement, our initial
stockholders, officers and directors and I-Bankers have agreed to vote their founder shares, private placement shares and representative
shares, as well as any public shares purchased during or after the IPO (including in open market and privately negotiated transactions),
in favor of our initial business combination. As a result, in addition to founder shares, private placement shares and representative
shares would need only 4,433,401 shares, or 35.0%, of the 12,650,000 public shares sold in the IPO to be voted in favor of an initial
business combination (assuming all outstanding shares are voted), or 325,101 shares, or 2.6%, the 12,650,000 public shares sold in the
IPO to be voted in favor of an initial business combination (assuming only a quorum is present), in order to have our initial business
combination approved. Our initial stockholders will own shares representing 20% of our outstanding shares of common stock immediately
following the completion of the IPO (not including the shares of Class A common stock underlying the private placement units or the representative
shares). Accordingly, if we seek stockholder approval of our initial business combination, the agreement by our initial stockholders to
vote in favor of our initial business combination will increase the likelihood that we will receive the requisite stockholder approval
for such initial business combination.
Your only opportunity to affect the investment
decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash,
unless we seek stockholder approval of the initial business combination.
At the time of your investment in us, you will
not be provided with an opportunity to evaluate the specific merits or risks of our initial business combination. Since our board of
directors may complete an initial business combination without seeking stockholder approval, public stockholders may not have the right
or opportunity to vote on the initial business combination, unless we seek such stockholder vote. Accordingly, if we do not seek stockholder
approval, your only opportunity to affect the investment decision regarding a potential business combination may be limited to exercising
your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed
to our public stockholders in which we describe our initial business combination.
The ability of our public stockholders to
redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it
difficult for us to enter into an initial business combination with a target.
We may seek to enter into an initial business
combination agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount
of cash. If too many public stockholders exercise their redemption rights, we would not be able to meet such closing condition and, as
a result, would not be able to proceed with the initial business combination. Furthermore, we will only redeem our public shares so long
as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our
initial business combination and after payment of underwriters’ fees and commissions (so that we are not subject to the SEC’s
“penny
stock” rules) or any greater net tangible
asset or cash requirement which may be contained in the agreement relating to our initial business combination. Consequently, if accepting
all properly submitted redemption requests would cause our net tangible assets to be less than $5,000,001 or such greater amount necessary
to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination and
may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus, may be reluctant
to enter into an initial business combination with us.
The ability of our public stockholders to
exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination
or optimize our capital structure.
At the time we enter into an agreement for our
initial business combination, we will not know how many stockholders may exercise their redemption rights, and therefore will need to
structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If our initial business
combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have
a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet such requirements, or
arrange for third party financing. In addition, if a larger number of shares are submitted for redemption than we initially expected,
we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third party financing.
Raising additional third party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable
levels. Furthermore, this dilution would increase to the extent that the anti-dilution provision of the Class B common stock result
in the issuance of Class A shares on a greater than one-to-one basis upon conversion of the Class B common stock at the time
of our business combination. The above considerations may limit our ability to complete the most desirable business combination available
to us or optimize our capital structure.
The ability of our public stockholders to
exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination
would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock.
If our initial business combination agreement
requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash
at closing, the probability that our initial business combination would be unsuccessful is increased. If our initial business combination
is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in
need of immediate liquidity, you could attempt to sell your stock in the open market; however, at such time our stock may trade at a discount
to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment or lose
the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your stock in the open market.
Because our trust account will initially
contain $10.10 per share of Class A common stock, public stockholders may be more incentivized to redeem their public shares at the time
of our initial business combination.
Our trust account will initially contain $10.10
per share of Class A common stock. This is different than some other similarly structured blank check companies for which the trust account
will only contain $10.00 per share of Class A common stock. As a result of the additional funds that could be available to public stockholders
upon redemption of public shares, our public stockholders may be more incentivized to redeem their public shares and not to hold those
shares of Class A common stock through our initial business combination. A higher percentage of redemptions by our public stockholders
could make it more difficult for us to complete our initial business combination.
Our sponsor may decide not to extend the
term we have to consummate our initial business combination, in which case we would cease all operations except for the purpose of winding
up and we would redeem our public shares and liquidate, and the rights will be worthless.
We will have until 12 months from the closing
of the IPO to consummate an initial business combination. However, if we anticipate that we may not be able to consummate our initial
business combination within 12 months, we may extend the period of time to consummate a business combination up to two times, each by
an additional three months (for a total of up to 18 months to complete a business combination). Pursuant to the terms of our amended and
restated certificate of incorporation and the trust agreement to be entered into between us and American Stock Transfer & Trust Company
on the date of completion of the IPO, in order to extend the time available for us to consummate our initial business combination, our
sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account
up to $1,265,000 ($0.10 per share) on or prior to the date of the applicable deadline, for each three month extension (or up to an aggregate
of $2,530,000, or $0.20 per share, if we extend for the full six months). Any such payments
would be made in the form of a loan. Any such
loans will be non-interest bearing and payable upon the consummation of our initial business combination. If we complete our initial business
combination, we would repay such loaned amounts out of the proceeds of the trust account released to us. If we do not complete a business
combination, we will not repay such loans. Furthermore, the letter agreement with our initial stockholders contains a provision pursuant
to which our sponsor has agreed to waive its right to be repaid for such loans out of the funds held in the trust account in the event
that we do not complete a business combination.
Our sponsor and its affiliates or designees
are not obligated to fund the trust account to extend the time for us to complete our initial business combination. If we are unable to
consummate our initial business combination within the applicable time period, we will, as promptly as reasonably possible but not more
than ten business days thereafter, redeem the public shares for a pro rata portion of the funds held in the trust account and as promptly
as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve
and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other
applicable law. In such event, the rights will be worthless.
Changes in the market for directors and
officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.
In recent months, the market for directors and
officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and our management team. The
premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. These
trends may continue into the future. The increased cost and decreased availability of directors and officers liability insurance could
make it more difficult and more expensive for us to negotiate an initial business combination. In order to obtain directors and officers
liability insurance or modify its coverage as a result of becoming a public company, the post-business combination entity might need to
incur greater expense, accept less favorable terms or both. However, any failure to obtain adequate directors and officers liability insurance
could have an adverse impact on the post-business combination’s ability to attract and retain qualified officers and directors.
In addition, even after we were to complete
an initial business combination, our directors and officers could still be subject to potential liability from claims arising from conduct
alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors and officers, the post-business
combination entity will likely need to purchase additional insurance with respect to any such claims (“run-off insurance”).
The need for run-off insurance would be an added expense for the post-business combination entity, and could interfere with or frustrate
our ability to consummate an initial business combination on terms favorable to our investors.
The requirement that we complete our initial
business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating an initial
business combination and may decrease our ability to conduct due diligence on potential business combination targets as we approach our
dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value
for our stockholders.
Any potential target business with which we
enter into negotiations concerning an initial business combination will be aware that we must complete our initial business combination
within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time to consummate
a business combination, as described in more detail in this Annual Report). Consequently, such target business may obtain leverage over
us in negotiating an initial business combination, knowing that if we do not complete our initial business combination with that particular
target business, we may be unable to complete our initial business combination with any target business. This risk will increase as we
get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may enter into our initial
business combination on terms that we would have rejected upon a more comprehensive investigation.
We may not be able to complete our initial
business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up
and we would redeem our public shares and liquidate, in which case our public stockholders may only receive $10.10 per share, or less
than such amount in certain circumstances, and our rights will expire worthless.
Our amended and restated certificate of incorporation
provides that we must complete our initial business combination within 12 months from the closing of the IPO (or up to 18 months from
the closing of the IPO if we extend the period of time to consummate a business combination, as described in more detail in this Annual
Report). We may not be able to find
a suitable target business and complete our
initial business combination within such time period. If we have not completed our initial business combination within such time period,
we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more
than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then
on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to us to
pay our franchise and income taxes (less up to $50,000 of interest to pay dissolution
expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law. In such case, our public stockholders may only receive $10.10 per share, and our rights will expire worthless.
In certain circumstances, our public stockholders may receive less than $10.10 per share on the redemption of their shares. See “—
If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by stockholders may be less than $10.10 per share” and other risk factors below.
If we seek stockholder approval of our initial
business combination, our sponsor, directors, officers and their affiliates may elect to purchase shares or rights from public stockholders,
which may influence a vote on a proposed initial business combination and reduce the public “float” of our Class A common
stock.
If we seek stockholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our sponsor, directors, officers or their affiliates may purchase shares or rights or a combination thereof in privately negotiated
transactions or in the open market either prior to or following the completion of our initial business combination, although they are
under no obligation to do so. However, they have no current commitments, plans or intentions to engage in such transactions and have not
formulated any terms or conditions for any such transactions. None of the funds in the trust account will be used to purchase shares or
rights in such transactions.
Such a purchase may include a contractual acknowledgement
that such stockholder, although still the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not
to exercise its redemption rights. In the event that our sponsor, directors, officers or their affiliates purchase shares in privately
negotiated transactions from public stockholders who have already elected to exercise their redemption rights, such selling stockholders
would be required to revoke their prior elections to redeem their shares. The purpose of such purchases could be to vote such shares in
favor of the initial business combination and thereby increase the likelihood of obtaining stockholder approval of the initial business
combination, or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain
amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise not be met.
The purpose of any such purchases of rights could be to reduce the number of rights, or underlying securities, outstanding. Any such purchases
of our securities may result in the completion of our initial business combination that may not otherwise have been possible. Any such
purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject
to such reporting requirements.
In addition, if such purchases are made, the
public “float” of our Class A common stock and the number of beneficial holders of our securities may be reduced, possibly
making it difficult to obtain or maintain the quotation, listing or trading of our securities on a national securities exchange.
If a stockholder fails to receive notice
of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for
tendering its shares, such shares may not be redeemed.
We will comply with the tender offer rules or
proxy rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with
these rules, if a stockholder fails to receive our tender offer or proxy materials, as applicable, such stockholder may not become aware
of the opportunity to redeem its shares. In addition, proxy materials or tender offer documents, as applicable, that we will furnish to
holders of our public shares in connection with our initial business combination will describe the various procedures that must be complied
with in order to validly tender or redeem public shares. For example, we may require our public stockholders seeking to exercise their
redemption rights, whether they are record holders or hold their shares in “street name,” to either tender their certificates
to our transfer agent prior to the date set forth in the tender offer documents mailed to such holders, or up to two business days prior
to the vote on the proposal to approve the initial business combination in the event we distribute proxy materials, or to deliver their
shares to the transfer agent electronically. In the event that a stockholder fails to comply with these or any other procedures, its shares
may not be redeemed. See the section of this Annual Report entitled “Proposed Business —
Redemption Rights for Public Stockholders upon
Completion of our Initial Business Combination — Tendering Stock Certificates in Connection with a Tender Offer or Redemption
Rights.”
You will not have any rights or interests
in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced
to sell your public shares or rights, potentially at a loss.
Our public stockholders will be entitled to
receive funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business combination, and
then only in connection with those shares of Class A common stock that such stockholder properly elected to redeem, subject to the
limitations described herein, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to
amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100%
of our public shares if we do not complete our initial business combination within 12 months from the closing of the IPO (or up to 18
months from the closing of the IPO if we extend the period of time to consummate a business combination,
as described in more detail in this Annual Report) or (B) with respect to any other provision relating to stockholders’ rights
or pre-initial business combination activity and (iii) the redemption of our public shares if we are unable to complete an initial
business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period
of time to consummate a business combination, as described in more detail in this Annual Report), subject to applicable law and as further
described herein. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Holders
of rights will not have any right to the proceeds held in the trust account with respect to the rights. Accordingly, to liquidate your
investment, you may be forced to sell your public shares or rights, potentially at a loss.
Nasdaq may delist our securities from trading
on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading
restrictions.
Our Class A common stock and rights are listed
on Nasdaq. Although we currently meet the minimum initial listing standards set forth in the Nasdaq listing standards, we cannot assure
you that our securities will be, or will continue to be, listed on Nasdaq in the future or prior to our initial business combination.
In order to continue listing our securities on Nasdaq prior to our initial business combination, we must maintain certain financial, distribution
and stock price levels. Generally, we must maintain a minimum amount in stockholders’ equity (generally $2,500,000) and a minimum
number of holders of our securities (generally 300 public holders). Additionally, in connection with our initial business combination,
we will be required to demonstrate compliance with Nasdaq’s initial listing requirements, which are more rigorous than Nasdaq’s
continued listing requirements, in order to continue to maintain the listing of our securities on Nasdaq. For instance, our stock price
would generally be required to be at least $4.00 per share, our stockholders’ equity would generally be required to be at least
$5.0 million and we would be required to have a minimum of 300 round lot holders of our securities. We cannot assure you that we will
be able to meet those initial listing requirements at that time.
If Nasdaq delists our securities from trading on its
exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted
on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:
|
• |
|
a limited availability of market quotations for our securities; |
|
|
|
|
|
• |
|
reduced liquidity for our securities; |
|
|
|
|
|
• |
|
a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
|
|
|
|
|
• |
|
a limited amount of news and analyst coverage; and |
|
|
|
|
|
• |
|
a decreased ability to issue additional securities or obtain additional financing in the future. |
The National Securities Markets Improvement
Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred
to as “covered securities.” Because we expect that our units and eventually our Class A common stock and rights will
be listed on Nasdaq, our units, Class A common stock and rights will be covered securities. Although the states are preempted from
regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud,
and, if there is a finding of fraudulent activity, then
the states can regulate or bar the sale of
covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of
securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies
unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in
their states. Further, if we were no longer listed on Nasdaq, our securities would not be covered securities and we would be subject to
regulation in each state in which we offer our securities, including in connection with our initial business combination.
You will not be entitled to protections
normally afforded to investors of many other blank check companies.
Since the net proceeds of the IPO and the sale
of the private placement units are intended to be used to complete an initial business combination with a target business that has not
been identified, we may be deemed to be a “blank check” company under the United States securities laws. However, because
we will have net tangible assets in excess of $5,000,000 upon the successful completion of the IPO and the sale of the private placement
units and will file a Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from
rules promulgated by the SEC to protect investors in blank check companies, such as Rule 419.
Accordingly, investors will not be afforded
the benefits or protections of those rules. Among other things, this means our units will be immediately tradable and we will have a longer
period of time to complete our initial business combination than do companies subject to Rule 419. Moreover, if the IPO were subject
to Rule 419, that rule would prohibit the release of any interest earned on funds held in the trust account to us unless and until
the funds in the trust account were released to us in connection with our completion of an initial business combination. For a more detailed
comparison of our offering to offerings that comply with Rule 419, please see the section of this Annual Report entitled “Proposed
Business — Comparison of This Offering to Those of Blank Check Companies Subject to Rule 419.”
If we seek stockholder approval of our initial
business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders
are deemed to hold in excess of 15% of our Class A common stock, you will lose the ability to redeem all such shares in excess of
15% of our Class A common stock.
If we seek stockholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated certificate of incorporation will provide that a public stockholder, together with any affiliate of such
stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13
of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold
in the IPO without our prior consent, which we refer to as the “Excess Shares.” However, we would not be restricting our stockholders’
ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Your inability to redeem
the Excess Shares will reduce your influence over our ability to complete our initial business combination and you could suffer a material
loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions
with respect to the Excess Shares if we complete our initial business combination. And as a result, you will continue to hold that number
of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your stock in open market transactions, potentially
at a loss.
Because of our limited resources and the
significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination.
If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.10 per share
on our redemption of our public shares, or less than such amount in certain circumstances, and our rights will expire worthless.
We expect to encounter intense competition from
other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships),
other blank check companies and other entities competing for the types of businesses we intend to acquire. Many of these individuals and
entities are well-established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies
operating in or providing services to various industries. Many of these competitors possess greater technical, human and other resources
or more industry knowledge than we do, and our financial resources will be relatively limited when contrasted with those of many of these
competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds of the IPO and the
sale of the private placement units, our ability to compete with respect to the acquisition of certain target businesses that are sizable
will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition
of certain target businesses. Furthermore, because we are obligated to pay cash for the shares of Class A common stock which our
public stockholders redeem in connection with our initial business combination, target companies will be aware that this may reduce the
resources available to us for our initial
business combination. This may place us at
a competitive disadvantage in successfully negotiating an initial business combination. If we are unable to complete our initial business
combination, our public stockholders may receive only approximately $10.10 per share on the liquidation of our trust account and our rights
will expire worthless. In certain circumstances, our public stockholders may receive less than $10.10 per share upon our liquidation.
See “— If third parties bring claims against us, the proceeds held in the trust account could be reduced and the
per-share redemption amount received by stockholders may be less than $10.10 per share” and other risk factors below.
If the net proceeds of the IPO and the sale
of the private placement units not being held in the trust account are insufficient to allow us to operate for at least the next 12 months
(up to 18 months), we may be unable to complete our initial business combination, in which case our public stockholders may only receive
$10.10 per share, or less than such amount in certain circumstances, and our rights will expire worthless.
The funds available to us outside of the trust
account may not be sufficient to allow us to operate for at least the next 12 months (up to 18 months), assuming that our initial business
combination is not completed during that time. We believe that, upon the closing of the IPO, the funds available to us outside of the
trust account will be sufficient to allow us to operate for at least the next 12 months (up to 18 months); however, we cannot assure you
that our estimate is accurate. Of the funds available to us, we could use a portion of the funds available to us to pay fees to consultants
to assist us with our search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop”
provision (a provision in letters of intent or merger agreements designed to keep target businesses from “shopping” around
for transactions with other companies on terms more favorable to such target businesses) with respect to a particular proposed initial
business combination, although we do not have any current intention to do so. If we entered into a letter of intent or merger agreement
where we paid for the right to receive exclusivity from a target business and were subsequently required
to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for,
or conduct due diligence with respect to, a target business. If we are unable to complete our initial business combination, our public
stockholders may receive only approximately $10.10 per share on the liquidation of our trust account and our rights will expire worthless.
In certain circumstances, our public stockholders may receive less than $10.10 per share upon our liquidation. See “— If third
parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by stockholders may be less than $10.10 per share” and other risk factors below.
If the net proceeds of the IPO and the sale
of the private placement units not being held in the trust account are insufficient, it could limit the amount available to fund our search
for a target business or businesses and complete our initial business combination and we will depend on loans from our sponsor or management
team to fund our search for an initial business combination, to pay our franchise and income taxes and to complete our initial business
combination. If we are unable to obtain these loans, we may be unable to complete our initial business combination.
Of the net proceeds of the IPO and the sale
of the private placement units, only $764,101 was available to us initially outside the trust account to fund our
working capital requirements. In the event that our offering expenses exceed our estimate of $500,000, we may fund such excess with funds
not to be held in the trust account. In such case, the amount of funds we intend to be held outside the trust account would decrease by
a corresponding amount. The amount held in the trust account will not be impacted as a result of such increase or decrease. Conversely,
in the event that the offering expenses are less than our estimate of $500,000, the amount of funds we intend to be held outside the trust
account would increase by a corresponding amount. If we are required to seek additional capital, we would need to borrow funds from our
sponsor, management team or other third parties to operate or may be forced to liquidate. None of our sponsor, members of our management
team nor any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid
only from funds held outside the trust account or from funds released to us upon completion of our initial business combination. Up to
$1,500,000 of such working capital loans may be convertible into private placement-equivalent units at a price of $10.00 per unit (which,
for example, would result in the holders being issued 165,000 shares of Class A common stock if $1,500,000 of notes were so converted
since the 150,000 rights included in such units would result in the issuance of 15,000 shares upon the closing of our business combination),
at the option of the lender. Prior to the completion of our initial business combination, we do not expect to seek loans from parties
other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide
a waiver against any and all rights to seek access to funds in our trust account. If we are unable to obtain these loans, we may be unable
to complete our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient
funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public stockholders may
only receive approximately $10.10 per share on our redemption of our public shares and our rights will expire worthless. In certain circumstances,
our public stockholders may receive less
than $10.10 per share on the redemption of
their shares. See “— If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the per-share redemption amount received by stockholders may be less than $10.10 per share” and other risk factors below.
Subsequent to the completion of our initial
business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have
a significant negative effect on our financial condition, results of operations and our stock price, which could cause you to lose some
or all of your investment.
Even if we conduct extensive due diligence on
a target business with which we combine, we cannot assure you that this diligence will surface all material issues that may be present
inside a particular target business, that it would be possible to uncover all material issues through a customary amount of due diligence,
or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be
forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in
our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known
risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and
not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions
about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be
subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining debt financing to partially
finance the initial business combination. Accordingly, any stockholders who choose to remain stockholders following the initial business
combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction
in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of
care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the proxy
solicitation or tender offer materials, as applicable, relating to the initial business combination constituted an actionable material
misstatement or omission.
If third parties bring claims against us,
the proceeds held in the trust account could be reduced and the per-share redemption amount received by stockholders may be less than
$10.10 per share.
Our placing of funds in the trust account may
not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers, prospective
target businesses and other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders,
such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims against
the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as
well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our
assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies
held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement
with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly
more beneficial to us than any alternative. MaloneBailey, LLP, our independent registered public accounting firm, and the underwriters
of the offering, will not execute agreements with us waiving such claims to the monies held in the trust account.
Examples of possible instances where we may
engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or
skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in
cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such
entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or
agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we are
unable to complete our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection
with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may
be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by public stockholders
could be less than the $10.10 per share initially held in the trust account, due to claims of such creditors. Pursuant to the letter agreement,
the form of which is filed as Exhibit 10.1 to the registration statement we filed in connection with the IPO, our sponsor has agreed that
it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective
target business with which we have entered into a written letter of intent, confidentiality or similar agreement or business combination
agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.10 per public share and (ii) the actual
amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.10 per share
due to reductions in the value of
the trust assets, less taxes payable, provided
that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all
rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity
of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, we have not asked
our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds
to satisfy its indemnity obligations and believe that our sponsor’s only assets are securities of our company. Therefore, we cannot
assure you that our sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims
by third parties including, without limitation, claims by vendors and prospective target businesses.
Our directors may decide not to enforce
the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution
to our public stockholders.
In the event that the proceeds in the trust
account are reduced below the lesser of (i) $10.10 per share and (ii) the actual amount per share held in the trust account as of
the date of the liquidation of the trust account if less than $10.10 per share due to reductions in the value of the trust assets, in
each case net of the interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations
or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take
legal action against our sponsor to enforce its indemnification obligations.
While we currently expect that our independent
directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that
our independent directors in exercising their business judgment and subject to their fiduciary duties may choose not to do so in any particular
instance if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable
or if the independent directors determine that a favorable outcome is not likely. If our independent directors choose not to enforce these
indemnification obligations, the amount of funds in the trust account available for distribution to our public stockholders may be reduced
below $10.10 per share.
We may not have sufficient funds to satisfy
indemnification claims of our directors and executive officers.
We have agreed to indemnify our officers and
directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest
or claim of any kind in or to any monies in the trust account and to not seek recourse against the trust account for any reason whatsoever.
Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the
trust account or (ii) we consummate an initial business combination. Our obligation to indemnify our officers and directors may
discourage stockholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an
action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely
affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification
provisions.
If, after we distribute the proceeds in
the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us
that is not dismissed, a bankruptcy court may seek to recover such proceeds, and we and our board may be exposed to claims of punitive
damages.
If, after we distribute the proceeds in the
trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that
is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as
either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover
all amounts received by our stockholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our
creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public stockholders
from the trust account prior to addressing the claims of creditors.
If, before distributing the proceeds in
the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us
that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our stockholders and the per-share
amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.
If, before distributing the proceeds in the
trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that
is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy
estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims
deplete the trust account, the per-share amount that would otherwise be received by our stockholders in connection with our liquidation
may be reduced.
If we are deemed to be an investment company under
the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which
may make it difficult for us to complete our initial business combination.
If we are deemed to be an investment company under
the Investment Company Act, our activities may be restricted, including:
|
• |
|
restrictions on the nature of our investments; and |
|
|
|
|
|
• |
|
restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
In addition, we may have imposed upon us burdensome
requirements, including:
|
• |
|
registration as an investment company; |
|
|
|
|
|
• |
|
adoption of a specific form of corporate structure; and |
|
|
|
|
|
• |
|
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
In order not to be regulated as an investment
company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business
other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding
or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities
and cash items) on an unconsolidated basis. Our business will be to identify and complete an initial business combination and thereafter
to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale
or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.
We do not believe that our anticipated principal
activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in
United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment
Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted
to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business
plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant
bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment
Company Act. This offering is not intended for persons who are seeking a return on investments in government securities or investment
securities. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of our
initial business combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to
amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100%
of our public shares if we do not complete our initial business combination within 12 months from the closing of the IPO (or up to 18
months from the closing of the IPO if we extend the period of time to consummate a business combination, as described in more detail in
this Annual Report) or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business
combination activity; or (iii) absent an initial business combination within 12 months from the closing of the IPO (or up to 18 months
from the closing of the IPO if we extend the period of time to consummate a business combination, as described in more detail in this
Annual Report), our return of the funds held in the trust account to our public stockholders as part of our redemption of the public shares.
If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to
be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which
we have not allotted funds and may hinder our ability to complete an initial business combination or
may result in our liquidation. If we are unable
to complete our initial business combination, our public stockholders may receive only approximately $10.10 per share on the liquidation
of our trust account and our rights will expire worthless.
Changes in laws or regulations, or a failure
to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial
business combination and results of operations.
We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements.
Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly.
Those laws and regulations and their interpretation
and application may also change from time to time and those changes could have a material adverse effect on our business, investments
and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have
a material adverse effect on our business, including our ability to negotiate and complete our initial business combination and results
of operations.
Our stockholders may be held liable for
claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
Under the DGCL, stockholders may be held liable
for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion
of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our
initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend
the period of time to consummate a business combination, as described in more detail in this Annual Report) may be considered a liquidating
distribution under Delaware law. If a corporation complies with certain procedures set forth in Section 280 of the DGCL intended
to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party
claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional
150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a
liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to
the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution. However, it is our
intention to redeem our public shares as soon as reasonably possible following the 15th month (or up to the 21st month) from the closing
of the IPO in the event we do not complete our initial business combination and, therefore, we do not intend to comply with the foregoing
procedures.
Because we will not be complying with Section 280,
Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment
of all existing and pending claims or claims that may be potentially brought against us within the 10 years following our dissolution.
However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective
target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or
prospective target businesses. If our plan of distribution complies with Section 281(b) of the DGCL, any liability of stockholders
with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount
distributed to the stockholder, and any liability of the stockholder would likely be barred after the third anniversary of the dissolution.
We cannot assure you that we will properly assess all claims that may be potentially brought against us. As such, our stockholders could
potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders
may extend beyond the third anniversary of such date. Furthermore, if the pro rata portion of our trust account distributed to our public
stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within 12 months
from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time to consummate a business combination,
as described in more detail in this Annual Report) is not considered a liquidating distribution under Delaware law and such redemption
distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings that a party may bring or due to other circumstances
that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then
be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution.
We may not hold an annual meeting of stockholders
until after the consummation of our initial business combination, which could delay the opportunity for our stockholders to elect directors.
In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual meeting until no later than one year after our first fiscal year end following our
listing on Nasdaq. Under Section 211(b) of the DGCL, we are,
however, required to hold an annual meeting
of stockholders for the purposes of electing directors in accordance with our bylaws unless such election is made by written consent in
lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new directors prior to the consummation of our initial
business combination, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore,
if our stockholders want us to hold an annual meeting prior to the consummation of our initial business combination, they may attempt
to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL.
Because we are neither limited to evaluating
a target business in a particular industry sector nor have we selected any specific target businesses with which to pursue our initial
business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations.
We will seek to complete an initial business
combination with a company in the healthcare and education service industries, but we may also pursue business combination opportunities
in any industry or geographic region, except that we will not, under our amended and restated certificate of incorporation, be permitted
to effectuate our initial business combination with another blank check company or similar company with nominal operations. Because we
have not yet selected or approached any specific target business with respect to a business combination, there is no basis to evaluate
the possible merits or risks of any particular target business’s operations, results of operations, cash flows, liquidity, financial
condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent in the
business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established
record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development
stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot
assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete
due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances
that those risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove
to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly,
any stockholders who choose to remain stockholders following our initial business combination could suffer a reduction in the value of
their securities. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim
that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they
are able to successfully bring a private claim under securities laws that the proxy solicitation or tender offer materials, as applicable,
relating to the business combination contained an actionable material misstatement or material omission.
Past performance by our management team
may not be indicative of future performance of an investment in the Company.
Past performance by our management team is not
a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to
locate a suitable candidate for our initial business combination. You should not rely on the historical record of our management team’s
performance as indicative of our future performance of an investment in the company or the returns the company will, or is likely to,
generate going forward.
We may seek business combination opportunities
in industries or sectors which may or may not be outside of our management’s area of expertise.
Although we intend to focus our search on the
healthcare and education service industries, we will consider an initial business combination outside of our management’s area of
expertise if an initial business combination candidate is presented to us and we determine that such candidate offers an attractive business
combination opportunity for our company or we are unable to identify a suitable candidate in this sector after having expanded a reasonable
amount of time and effort in an attempt to do so. Although our management will endeavor to evaluate the risks inherent in any particular
business combination candidate, we cannot assure you that we will adequately ascertain or assess all of the significant risk factors.
We also cannot assure you that an investment in our units will not ultimately prove to be less favorable to investors in the IPO than
a direct investment, if an opportunity were available, in an initial business combination candidate. In the event we elect to pursue a
business combination outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable
to its evaluation or operation, and the information contained in this Annual Report regarding the areas of our management’s expertise
would not be relevant to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately
ascertain or assess all of the significant risk factors. Accordingly, any stockholders who choose to remain stockholders following our
initial business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for
such reduction in value.
Although we have identified general criteria
and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination
with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial
business combination may not have attributes entirely consistent with our general criteria and guidelines.
Although we have identified general criteria
and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial
business combination will not have all of these positive attributes. If we complete our initial business
combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a combination
with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination
with a target that does not meet our general criteria and guidelines, a greater number of stockholders may exercise their redemption rights,
which may make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or
a certain amount of cash. In addition, if stockholder approval of the transaction is required by law, or we decide to obtain stockholder
approval for business or other legal reasons, it may be more difficult for us to attain stockholder approval of our initial business combination
if the target business does not meet our general criteria and guidelines. If we are unable to complete our initial business combination,
our public stockholders may receive only approximately $10.10 per share on the liquidation of our trust account and our rights will expire
worthless. In certain circumstances, our public stockholders may receive less than $10.10 per share on the redemption of their shares.
See “— If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share
redemption amount received by stockholders may be less than $10.10 per share” and other risk factors below.
We may seek business combination opportunities
with a financially unstable business or an entity lacking an established record of revenue, cash flow or earnings, which could subject
us to volatile revenues, cash flows or earnings or difficulty in retaining key personnel.
To the extent we complete our initial business
combination with a financially unstable business or an entity lacking an established record of revenues or earnings, we may be affected
by numerous risks inherent in the operations of the business with which we combine. These risks include volatile revenues or earnings
and difficulties in obtaining and retaining key personnel. Although our officers and directors will endeavor to evaluate the risks inherent
in a particular target business, we may not be able to properly ascertain or assess all of the significant risk factors and we may not
have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability
to control or reduce the chances that those risks will adversely impact a target business.
We are not required to obtain an opinion
from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance from an
independent source that the price we are paying for the business is fair to our company from a financial point of view.
Unless we complete our initial business combination
with an affiliated entity or our board cannot independently determine the fair market value of the target business or businesses, we are
not required to obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting
firm that the price we are paying is fair to our company from a financial point of view. If no opinion is obtained, our stockholders will
be relying on the judgment of our board of directors, who will determine fair market value based on standards generally accepted by the
financial community. Such standards used will be disclosed in our proxy materials or tender offer documents, as applicable, related to
our initial business combination.
We may issue additional common stock or
preferred stock to complete our initial business combination or under an employee incentive plan after completion of our initial business
combination. We may also issue shares of Class A common stock upon the conversion of the Class B common stock at a ratio greater
than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our amended and
restated certificate of incorporation. Any such issuances would dilute the interest of our stockholders and likely present other risks.
Our amended and restated certificate of incorporation
authorizes the issuance of up to 100,000,000 shares of Class A common stock, par value $0.0001 per share, 10,000,000 shares of Class B
common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. As of March 31, 2022,
there are 86,729,300 and 6,837,500 authorized but unissued shares of Class A common stock and Class B common stock, respectively,
available for issuance, which amount does not take into account the shares of Class A common stock reserved for issuance upon conversion
of outstanding rights and the issuance of shares pursuant to the exercise of the representative’s warrants or the additional shares
of Class A common stock issuable upon
conversion of Class B common stock, subject to adjustment. Immediately after the consummation of the IPO, there will be no shares
of preferred stock issued and outstanding. Shares of Class B common stock are convertible into shares of our Class A common
stock initially at a one-for-one ratio but subject to adjustment as set forth herein, including in certain circumstances in which we issue
Class A common stock or equity-linked securities related to our initial business combination. Shares of Class B common stock
are also convertible at the option of the holder at any time.
We may issue a substantial number of additional
shares of common or preferred stock to complete our initial business combination or under an employee incentive plan after completion
of our initial business combination (although our amended and restated certificate of incorporation will provide that we may not issue
securities that can vote with common stockholders on matters related to our pre-initial business combination activity). The price at which
we issue any shares may be lower than the price you paid for the units in the IPO or at a price lower than the trading price of our Class
A common stock at the time we commit to such issuance or at the actual issuance of such shares. We may also issue shares of Class A
common stock upon conversion of the Class B common stock at a ratio greater than one-to-one at the time of our initial business combination
as a result of the anti-dilution provisions contained in our amended and restated certificate of incorporation. However, our amended and
restated certificate of incorporation will provide, among other things, that prior to our initial business combination, we may not issue
additional shares of capital stock that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote
on any initial business combination. These provisions of our amended and restated certificate of incorporation, like all provisions of
our amended and restated certificate of incorporation, may be amended with the approval of our stockholders. However, our executive officers,
directors and director nominees have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our
amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100% of our public
shares if we do not complete our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the
closing of the IPO if we extend the period of time to consummate a business combination, as described in more detail in this Annual Report)
or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless
we provide our public stockholders with the opportunity to redeem their shares of common stock upon approval of any such amendment at
a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest
shall be net of taxes payable), divided by the number of then outstanding public shares.
The issuance of additional shares of common
or preferred stock:
|
• |
|
may significantly dilute the equity interest of investors in the IPO; |
|
|
|
|
|
• |
|
may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
|
|
|
|
|
• |
|
could cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
|
|
|
|
|
• |
|
may adversely affect prevailing market prices for our units, Class A common stock and/or rights. |
Resources could be wasted in researching
business combinations that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge
with another business. If we are unable to complete our initial business combination, our public stockholders may receive only approximately
$10.10 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our rights will expire
worthless.
We anticipate that the investigation of each
specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments
will require substantial management time and attention and substantial costs for accountants, attorneys, consultants and others. If we
decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely
would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial
business combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related
costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we
are unable to complete our initial business combination, our public stockholders may receive only approximately $10.10 per share on the
liquidation of our trust account and our rights will expire worthless. In certain circumstances, our
public stockholders may receive less than $10.10
per share on the redemption of their shares. See “— If third parties bring claims against us, the proceeds held in the trust
account could be reduced and the per-share redemption amount received by stockholders may be less than $10.10 per share” and other
risk factors below.
We may issue notes or other debt securities,
or otherwise incur substantial debt, to complete an initial business combination, which may adversely affect our leverage and financial
condition and thus negatively impact the value of our stockholders’ investment in us.
Although we have no commitments as of the date
of this Annual Report to issue any notes or other debt securities, or to otherwise incur outstanding debt following the IPO, we may choose
to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless
we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account.
As such, no issuance of debt will affect the per-share amount available for redemption from the trust account. Nevertheless, the incurrence
of debt could have a variety of negative effects, including:
|
• |
|
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|
|
|
|
|
• |
|
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
|
|
|
|
|
• |
|
our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
|
|
|
|
|
• |
|
our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
|
|
|
|
|
• |
|
our inability to pay dividends on our common stock; |
|
|
|
|
|
• |
|
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
|
|
|
|
|
• |
|
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|
|
|
|
|
• |
|
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
|
|
|
|
|
• |
|
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
|
|
|
|
|
• |
|
other disadvantages compared to our competitors who have less debt. |
We may issue our shares of common stock
to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares
at that time.
In connection with our initial business combination,
we may issue shares of common stock to investors in private placement transactions (so-called PIPE transactions) at a price of $10.10
per share or which approximates the per-share amounts in our trust account at such time, which is generally approximately $10.10. The
purpose of such issuances will be to enable us to provide sufficient liquidity to the post-business combination entity. The price of the
shares we issue may therefore be less, and potentially significantly less, than the market price for our shares at such time.
We may only be able to complete one business
combination with the proceeds of the IPO and the sale of the private placement units, which will cause us to be solely dependent on a
single business which may have a limited number of services and limited operating activities. This lack of diversification may negatively
impact our operating results and profitability.
Of the net proceeds from the IPO and the sale
of the private placement units, $126,500,000 will be available to complete our initial business combination and pay related fees and expenses.
We may effectuate our initial business combination
with a single target business or multiple target businesses simultaneously or within a short period of time. However, we may not be able
to effectuate our initial business combination with more than one target business because of various factors, including the existence
of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating
results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial
business combination with only a single entity, our lack of diversification may subject us to numerous economic, competitive and regulatory
developments. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting
of losses, unlike other entities which may have the resources to complete several business combinations in different industries or different
areas of a single industry. In addition, we intend to focus our search for an initial business combination in a single industry. Accordingly,
the prospects for our success may be:
|
• |
|
solely dependent upon the performance of a single business, property or asset, or |
|
|
|
|
|
• |
|
dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
This lack of diversification may subject us
to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular
industry in which we may operate subsequent to our initial business combination.
We may attempt to simultaneously complete
business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and
give rise to increased costs and risks that could negatively impact our operations and profitability.
If we determine to simultaneously acquire several
businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent
on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete
our initial business combination. We do not, however, intend to purchase multiple businesses in unrelated industries in conjunction with
our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens
and costs with respect to possible multiple negotiations and due diligence investigations
(if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or
products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively
impact our profitability and results of operations.
We may attempt to complete our initial business
combination with a private company about which little information is available, which may result in an initial business combination with
a company that is not as profitable as we suspected, if at all.
In pursuing our initial business combination
strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally
exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business combination
on the basis of limited information, which may result in an initial business combination with a company that is not as profitable as we
suspected, if at all.
Our management may not be able to maintain
control of a target business after our initial business combination.
We may structure an initial business combination
so that the post-transaction company in which our public stockholders own shares will own less than 100% of the equity interests or assets
of a target business, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more
of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to
be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not
meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our stockholders
prior to the initial business combination may
collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in
the initial business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares of Class A
common stock in exchange for all of the outstanding capital stock of a target.
In this case, we would acquire a 100% interest
in the target. However, as a result of the issuance of a substantial number of new shares of common stock, our stockholders immediately
prior to such transaction could own less than a majority of our outstanding shares of common stock subsequent to such transaction. In
addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining a larger
share of the company’s stock than we initially acquired. Accordingly, this may make it more likely that our management will not
be able to maintain our control of the target business. We cannot provide assurance that, upon loss of control of a target business, new
management will possess the skills, qualifications or abilities necessary to profitably operate such business.
We do not have a specified maximum redemption
threshold. The absence of such a redemption threshold may make it possible for us to complete an initial business combination with which
a substantial majority of our stockholders do not agree.
Our amended and restated certificate of incorporation
will not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of our initial business
combination and after payment of underwriters’ fees and commissions (such that we are not subject to the SEC’s “penny
stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial
business combination. As a result, we may be able to complete our initial business combination even though a substantial majority of our
public stockholders do not agree with the transaction and have redeemed their shares or, if we seek stockholder approval of our initial
business combination and do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules,
have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates.
In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stock that are validly
submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed initial business combination
exceed the aggregate amount of cash available to us, we will not complete the initial business combination or redeem any shares, all shares
of Class A common stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate
business combination.
In order to effectuate an initial business
combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing instruments.
We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments in
a manner that will make it easier for us to complete our initial business combination that our stockholders may not support.
In order to effectuate an initial business combination,
blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. For example,
blank check companies have amended the definition of business combination, increased redemption thresholds and extended the time to consummate
an initial business combination. Amending our amended and restated certificate of incorporation requires the approval of holders of 65%
of our common stock. In addition, our amended and restated certificate of incorporation requires us to provide our public stockholders
with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated certificate of incorporation
(A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business
combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time
to consummate a business combination, as described in more detail in this Annual Report) or (B) with respect to any other provision
relating to stockholders’ rights or pre-initial business combination activity. To the extent any such amendments would be deemed
to fundamentally change the nature of any securities offered through this registration statement, we would register, or seek an exemption
from registration for, the affected securities. We cannot assure you that we will not seek to amend our charter or governing instruments
or extend the time to consummate an initial business combination in order to effectuate our initial business combination.
The provisions of our amended and restated
certificate of incorporation that relate to our pre-business combination activity (and corresponding provisions of the agreement governing
the release of funds from our trust account), including an amendment to permit us to withdraw funds from the trust account such that the
per share amount investors will receive upon any redemption or liquidation is substantially reduced or eliminated, may be amended with
the approval of holders of 65% of our common stock, which is a lower amendment threshold than that of some other blank check companies.
It may be easier for us, therefore, to amend our amended and restated certificate of
incorporation and the trust agreement to
facilitate the completion of an initial business combination that some of our stockholders may not support.
Our amended and restated certificate of incorporation
will provide that any of its provisions related to pre-initial business combination activity (including the requirement to deposit proceeds
of the IPO and the private placement of units into the trust account and not release such amounts except in specified circumstances, and
to provide redemption rights to public stockholders as described herein and including to permit us to withdraw funds from the trust account
such that the per share amount investors will receive upon any redemption or liquidation is substantially reduced or eliminated) may be
amended if approved by holders of 65% of our common stock entitled to vote thereon, and corresponding provisions of the trust agreement
governing the release of funds from our trust account may be amended if approved by holders of 65% of our common stock entitled to vote
thereon. In all other instances, our amended and restated certificate of incorporation may be amended by holders of a majority of our
outstanding common stock entitled to vote thereon, subject to applicable provisions of the DGCL or applicable stock exchange rules. We
may not issue additional securities that can vote on amendments to our amended and restated certificate of incorporation. Our initial
stockholders, who will collectively beneficially own up to 20% of our common stock upon the closing of the IPO (not including the shares
of Class A common stock underlying the private placement units or the representative shares and assuming they do not purchase any
units in the IPO), will participate in any vote to amend our amended and restated certificate of incorporation and/or trust agreement
and will have the discretion to vote in any manner they choose. As a result, we may be able to amend the provisions of our amended and
restated certificate of incorporation which govern our pre-initial business combination behavior more easily than some other blank check
companies, and this may increase our ability to complete an initial business combination with which you do not agree. Our stockholders
may pursue remedies against us for any breach of our amended and restated certificate of incorporation.
Our initial stockholders, officers and directors
have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our amended and restated certificate
of incorporation (i) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend
the period of time to consummate a business combination, as described in more detail in this Annual Report) or (ii) with respect
to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless we provide our public
stockholders with the opportunity to redeem their shares of Class A common stock upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, divided by the number of then outstanding
public shares. These agreements are contained in a letter agreement that we have entered into with our initial stockholders, officers
and directors and I-Bankers. Our stockholders are not parties to, or third-party beneficiaries of, these agreements and, as a result,
will not have the ability to pursue remedies against our initial stockholders, officers or directors for any breach of these agreements.
As a result, in the event of a breach, our stockholders would need to pursue a stockholder derivative action, subject to applicable law.
We may be unable to obtain additional financing
to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure
or abandon a particular business combination.
We have not selected any specific business combination
target, but intend to target businesses larger than we could acquire with the net proceeds of the IPO and the sale of the private placement
units. As a result, we may be required to seek additional financing to complete such proposed initial business combination. We cannot
assure you that such financing will be available on acceptable terms, if at all. To the extent that additional financing proves to be
unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon
that particular business combination and seek an alternative target business candidate. Further, the amount of additional financing we
may be required to obtain could increase as a result of future growth capital needs for any particular transaction, the depletion of the
available net proceeds in search of a target business, the obligation to repurchase for cash a significant number of shares from stockholders
who elect redemption in connection with our initial business combination and/or the terms of negotiated transactions to purchase shares
in connection with our initial business combination. If we are unable to complete our initial business combination, our public stockholders
may receive only approximately $10.10 per share plus any pro rata interest earned on the funds held in the trust account and not previously
released to us to pay our franchise and income taxes on the liquidation of our trust account and our rights will expire worthless. In
addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to fund
the operations or growth of the target business. The failure to secure additional financing could have a material adverse effect on the
continued development or growth of the target business. None of our officers, directors or stockholders is required to provide any financing
to us in connection with or after our initial business combination. If we are unable to complete our initial business
combination, our public stockholders may only
receive approximately $10.10 per share on the liquidation of our trust account, and our rights will expire worthless. Furthermore, as
described in the risk factor entitled “If third parties bring claims against us, the proceeds held in the trust account could be
reduced and the per-share redemption amount received by stockholders may be less than $10.10 per share,” under certain circumstances
our public stockholders may receive less than $10.10 per share upon the liquidation of the trust account.
Our initial stockholders may exert a substantial
influence on actions requiring a stockholder vote, potentially in a manner that you do not support.
Upon the closing of the IPO, our initial stockholders
own shares representing 20.0% of our issued and outstanding shares of common stock (not including the shares of Class A common stock underlying
the private placement units or the representative shares and assuming they do not purchase any units in the IPO). Accordingly, they may
exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you do not support, including amendments
to our amended and restated certificate of incorporation and approval of major corporate transactions. If our initial stockholders purchase
any units in the IPO or if our initial stockholders purchase any additional shares of common stock in the aftermarket or in privately
negotiated transactions, this would increase their control. Factors that would be considered in making such additional purchases would
include consideration of the current trading price of our Class A common stock. In addition, our board of directors, whose members
were elected by our initial stockholders, is and will be divided into two classes, each of which will generally serve for a term of two
years with only one class of directors being elected in each year. We may not hold an annual meeting of stockholders to elect new directors
prior to the completion of our initial business combination, in which case all of the current directors will continue in office until
at least the completion of the initial business combination. If there is an annual meeting, as a consequence of our “staggered”
board of directors, only a minority of the board of directors will be considered for election and our initial stockholders, because of
their ownership position, will have considerable influence regarding the outcome. Accordingly, our initial stockholders will continue
to exert control at least until the completion of our initial business combination.
Our search for a business combination, and
any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus
(COVID-19) outbreak.
The significant outbreak of COVID-19 has resulted
in a widespread health crisis that could adversely affect the economies and financial markets worldwide, and the business of any potential
target business with which we consummate a business combination could be materially and adversely affected. We may be unable to complete
a business combination if continued concerns relating to COVID-19 restrict travel, limit the ability to have meetings with potential investors
or the target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a
timely manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are
highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions
to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue
for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which we
ultimately consummate a business combination, may be materially adversely affected.
As the number of SPACs evaluating targets
increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost
of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
In recent years and especially in the last several
months, the number of SPACs that have been formed has increased substantially. Many potential targets for SPACs have already entered into
an initial business combination, and there are still many SPACs seeking targets for their initial business combination, as well as many
such companies currently in registration. As a result, at times, fewer attractive targets may be available, and it may require more time,
more effort and more resources to identify a suitable target and to consummate an initial business combination.
In addition, because there are more SPACs seeking
to enter into an initial business combination with available targets, the competition for available targets with attractive fundamentals
or business models may increase, which could cause targets companies to demand improved financial terms. Attractive deals could also become
scarcer for other reasons, such as economic or industry sector downturns, geopolitical tensions, or increases in the cost of additional
capital needed to close business combinations or operate targets post-business combination. This could increase the cost of, delay or
otherwise complicate or frustrate our ability to find and consummate an initial business combination, and may result in our inability
to consummate an initial business combination on terms favorable to our investors altogether.
Since our officers and directors will receive
an aggregate of 300,000 post business combination shares within 10 days of our business combination, a conflict of interest may arise
in determining whether a particular business combination target is appropriate for our initial business combination.
We will also issue to our officers and directors
an aggregate of 300,000 post business combination shares within 10 days following the business combination, with the same lock-up restrictions
and registration rights as the founder shares. These officers and directors, except Weixuan Luo, our Chief Financial Officer, will not
receive any cash compensation from us prior to a business combination. Investors should be aware that this structure also creates an incentive
whereby our officers and directors could potentially make a substantial profit even if we complete a business combination with a target
that ultimately declines in value and is not profitable for public investors.
We may engage one or more of our underwriters
or one of their respective affiliates to provide additional services to us after the IPO, which may include acting as financial advisor
in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters
are entitled to receive business combination marketing fees that will be released from the trust account only upon a completion of an
initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such
additional services to us after the IPO, including, for example, in connection with the sourcing and consummation of an initial business
combination.
We may engage one or more of our underwriters
or one of their respective affiliates to provide additional services to us after the IPO, including, for example, identifying potential
targets, providing financial advisory services, acting as a placement agent in a private offering or arranging debt financing transactions.
We may pay such underwriter or its affiliate fair and reasonable fees or other compensation that would be determined at that time in an
arm’s length negotiation; provided that no agreement will be entered into with any of the underwriters or their respective affiliates
and no fees or other compensation for such services will be paid to any of the underwriters or their respective affiliates prior to the
date that is 60 days from the date of the prospectus we filed in connection with the IPO, unless such payment would not be deemed underwriters’
compensation in connection with the IPO. In addition, under a business combination marketing agreement, we will engage I-Bankers as an
advisor in connection with our business combination and will pay I-Bankers a cash fee for such marketing services upon the consummation
of our initial business combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the IPO, including any proceeds
from the full or partial exercise of the underwriters’ over-allotment option. The underwriters’ or their respective affiliates’
financial interests tied to the consummation of a business combination transaction may give rise to potential conflicts of interest in
providing any such additional services to us, including potential conflicts of interest in connection with the sourcing and consummation
of an initial business combination.
Risks Relating to our Sponsor and Management
Team
Our ability to successfully effect our initial
business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may
join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability
of our post-combination business.
Our ability to successfully effect our initial
business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however,
cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management or advisory
positions following our initial business combination, it is likely that some or all of the management of the target business will remain
in place. While we intend to closely scrutinize any individuals we employ after our initial business combination, we cannot assure you
that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating
a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.
In addition, the officers and directors of an initial business combination candidate may resign upon completion of our initial business
combination. The departure of an initial business combination target’s key personnel could negatively impact the operations and
profitability of our post-combination business. The role of an initial business combination candidate’s key personnel upon the completion
of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an initial business
combination candidate’s management team will remain associated with the initial business combination candidate following our initial
business combination, it is possible that members of the management of an initial business combination candidate will not wish to
remain in place. The loss of key personnel
could negatively impact the operations and profitability of our post-combination business.
We are dependent upon our executive officers
and directors and their departure could adversely affect our ability to operate.
Our operations are dependent upon a relatively
small group of individuals and, in particular, our executive officers and directors. We believe that our success depends on the continued
service of our executive officers and directors, at least until we have completed our initial business combination. We do not have an
employment agreement with, or key-man insurance on the life of, any of our directors or executive officers. The unexpected loss of the
services of one or more of our directors or executive officers could have a detrimental effect on us.
Our key personnel may negotiate employment
or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for
them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest
in determining whether a particular business combination is the most advantageous.
Our key personnel may be able to remain with
the company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements
in connection with the initial business combination. Such negotiations would take place simultaneously with the negotiation of the initial
business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities
for services they would render to us after the completion of the initial business combination. The personal and financial interests of
such individuals may influence their motivation in identifying and selecting a target business. However, we believe the ability of such
individuals to remain with us after the completion of our initial business combination will not be the determining factor in our decision
as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any of our key personnel
will remain with us after the completion of our initial business combination. We cannot assure you that any of our key personnel will
remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with us
will be made at the time of our initial business combination.
We may have a limited ability to assess the
management of a prospective target business and, as a result, may effect our initial business combination with a target business whose
management may not have the skills, qualifications or abilities to manage a public company, which could, in turn, negatively impact the
value of our stockholders’ investment in us.
When evaluating the desirability of effecting
our initial business combination with a prospective target business, our ability to assess the target business’s management may
be limited due to a lack of time, resources or information. Our assessment of the capabilities of the target’s management, therefore,
may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target’s
management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability
of the post-combination business may be negatively impacted. Accordingly, any stockholders who choose to remain stockholders following
the initial business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy
for such reduction in value.
Our officers and directors will allocate
their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs.
This conflict of interest could have a negative impact on our ability to complete our initial business combination.
Our officers and directors are not required
to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our
operations and our search for an initial business combination and their other businesses. We do not intend to have any full-time employees
prior to the completion of our initial business combination. Each of our officers is engaged in other business endeavors for which he
may be entitled to substantial compensation and our officers are not obligated to contribute any specific number of hours per week to
our affairs. Our independent directors may also serve as officers or board members for other entities. If our officers’ and directors’
other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels,
it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial business
combination. For a complete discussion of our officers’ and directors’ other business affairs, please see the section of this
Annual Report entitled “Management — Directors and Officers.”
Certain of our officers and directors are
now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be
conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining to which entity a particular
business opportunity should be presented.
Following the completion of the IPO and until
we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses.
Our sponsor and officers and directors are, and may in the future become, affiliated with entities (such as operating companies or investment
vehicles) that are engaged in a similar business, although they may not participate in the formation of, or become an officer or director
of, any other special purpose acquisition companies with a class of securities registered under the Exchange Act until we have entered
into a definitive agreement regarding our initial business combination or we have failed to complete our initial business combination
within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if we extend the period of time to consummate
a business combination, as described in more detail in this Annual Report).
Our officers and directors also may become aware
of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or
contractual duties.
Accordingly, they may have conflicts of interest
in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor
and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate
of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such
opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity
is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the
director or officer is permitted to refer that opportunity to us without violating another legal obligation.
For a complete discussion of our officers’
and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see the sections
of this Annual Report entitled “Management — Directors and Officers,” “Management — Conflicts
of Interest” and “Certain Relationships and Related Party Transactions.”
Our officers, directors, security holders
and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
We have not adopted a policy that expressly
prohibits our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in
any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may
enter into an initial business combination with a target business that is affiliated with our sponsor, our directors or officers, although
we do not intend to do so. We do not have a policy that expressly prohibits any such persons from engaging for their own account in business
activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.
We may engage in an initial business combination
with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, officers, directors
or existing holders which may raise potential conflicts of interest.
In light of the involvement of our sponsor,
officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, officers or directors.
Our directors also serve as officers and board members for other entities, including, without limitation, those described under the section
of this Annual Report entitled “Management — Conflicts of Interest.” Such entities may compete with us for business
combination opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete
our initial business combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning
an initial business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any
transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria
for an initial business combination as set forth in the section of this Annual Report entitled “Proposed Business — Selection
of a Target Business and Structuring of our Initial Business Combination” and such transaction was approved by a majority of our
disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm that is a member of FINRA,
or from an independent accounting firm, regarding the fairness to our stockholders from a financial point of view of an initial business
combination with one or more domestic or international businesses affiliated with our officers, directors or existing holders, potential
conflicts of interest still may exist and, as a result, the terms of the initial business combination may not be as advantageous to our
public stockholders as they would be absent any conflicts of interest.
Members of our management team and board
of directors have significant experience as founders, board members, officers, executives or employees of other companies. While they
are not currently, certain of those persons may become involved in litigation, investigations or other proceedings, including related
to those companies or otherwise. The defense or prosecution of these matters could be time-consuming and could divert our management’s
attention, and may have an adverse effect on us, which may impede our ability to consummate an initial business combination.
During the course of their careers, members
of our management team and board of directors have had significant experience as founders, board members, officers, executives or employees
of other companies. As a result of their involvement and positions in these companies, while they are not currently, certain of those
persons may in the future become involved in litigation, investigations or other proceedings, including relating to the business affairs
of such companies, transactions entered into by such companies, or otherwise. While they are not currently, individual members of our
management team and board of directors also may become involved in litigation, investigations or other proceedings involving claims or
allegations related to or as a result of their previous personal conduct, either in their capacity as a corporate officer or director
or otherwise, and may be personally named in such actions and potentially subject to personal liability as a result of their previous
individual conduct or otherwise. Any such liability may or may not be covered by insurance and/or indemnification, depending on the facts
and circumstances. The defense or prosecution of these matters could be time-consuming. Any litigation, investigations or other proceedings
and the potential outcomes of such actions may divert the attention and resources of our management team and board of directors away
from identifying and selecting a target business or businesses for our initial business combination and may negatively affect our reputation,
which may impede our ability to complete an initial business combination.
Since our initial stockholders will lose
their entire investment in us if our initial business combination is not completed, a conflict of interest may arise in determining whether
a particular business combination target is appropriate for our initial business combination.
In March 2021, our initial stockholders purchased
an aggregate of 2,875,000 founder shares for an aggregate purchase price of $50,000, or approximately $0.017 per share. In October 2021,
we effected a 0.1 for 1 stock dividend for each share of Class B common stock outstanding, resulting in our sponsor holding an aggregate
of 3,162,500 founder shares. The number of founder shares issued was determined based on the expectation that such founder shares would
represent 20% of the outstanding shares after the IPO (not including the shares of Class A common stock underlying the private placement
units or the representative shares). The founder shares will be worthless if we do not complete an initial business combination. In addition,
our sponsor purchased an aggregate of 406,500 units at a price of $10.00 per unit, for an aggregate purchase price of $4,065,000 and I-Bankers
purchased an aggregate of 113,000 units at a price of $10.00 per unit, for an aggregate purchase price of $1,130,000, that will also be
worthless if we do not complete an initial business combination. Holders of founder shares and private placement shares have agreed (A) to
vote any shares owned by them in favor of any proposed initial business combination and (B) not to redeem any founder shares or private
placement shares in connection with a stockholder vote to approve a proposed initial business combination or in connection with a tender
offer. We will issue to our officers and our directors an aggregate of 300,000 post business combination shares within 10 days following
the business combination with the same lock-up restrictions and registration rights as the founder shares. In addition, we may obtain
loans from our sponsor, affiliates of our sponsor or an officer or director. The personal and financial interests of our officers and
directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination
and influencing the operation of the business following the initial business combination.
The determination of the offering price
of our units and the size of the IPO is more arbitrary than the pricing of securities and size of an offering of an operating company
in a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of
such units than you would have in a typical offering of an operating company.
Prior to the IPO there has been no public market
for any of our securities. The public offering price of the units and the terms of the rights were negotiated between us and the underwriters.
In determining the size of the IPO, management held customary organizational meetings with representatives of the underwriters, both prior
to our inception and thereafter, with respect to the state of capital markets, generally, and the amount the underwriters believed they
reasonably could raise on our behalf.
Factors considered in determining the size
of the IPO, prices and terms of the units, including the Class A common stock and rights underlying the units, include:
|
• |
|
the history and prospects of companies whose principal business is the acquisition of other companies; |
|
• |
|
prior offerings of those companies; |
|
|
|
|
|
• |
|
our prospects for acquiring an operating business; |
|
|
|
|
|
• |
|
a review of debt to equity ratios in leveraged transactions; |
|
|
|
|
|
• |
|
our capital structure; |
|
|
|
|
|
• |
|
an assessment of our management and their experience in identifying operating companies; |
|
|
|
|
|
• |
|
general conditions of the securities markets at the time of the IPO; and |
|
|
|
|
|
• |
|
other factors as were deemed relevant. |
Although these factors were considered, the
determination of our offering price is more arbitrary than the pricing of securities of an operating company in a particular industry
since we have no historical operations or financial results.
Risks Relating to our Securities
There is currently no market for our securities
and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities.
There is currently no market for our securities.
Stockholders therefore have no access to information about prior market history on which to base their investment decision. Following
the IPO, the price of our securities may vary significantly due to one or more potential business combinations and general market or economic
conditions. Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained. You
may be unable to sell your securities unless a market can be established and sustained.
Because we must furnish our stockholders
with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination
with some prospective target businesses.
The federal proxy rules require that a proxy
statement with respect to a vote on an initial business combination meeting certain financial significance tests include historical and/or
pro forma financial statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with
our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required
to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America,
or GAAP, or international financial reporting standards as issued by the International Accounting Standards Board, or IFRS, depending
on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the Public
Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool of potential
target businesses we may acquire because some targets may be unable to provide such financial statements in time for us to disclose such
statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.
Our initial stockholders paid an aggregate
of $50,000, or approximately $0.017 per founder share, and, accordingly, investors in our IPO experienced immediate and substantial dilution
from the purchase of our Class B common stock.
The difference between the public offering price
per share (allocating $9.09 of the unit purchase price to the Class A common stock and $0.91 to the rights included in the unit)
and the pro forma net tangible book value per share of our Class A common stock after the IPO constitutes the dilution to you and
the other investors in the IPO. Our initial stockholders acquired the founder shares at a nominal price, significantly contributing to
this dilution. Upon the closing of the IPO, and assuming $0.91 is ascribed to the rights included in the units, you and the other public
stockholders will incur an immediate and substantial dilution of approximately 107.70% (or $9.79 per share), the difference between
the pro forma net tangible book value per share of $(0.70) and the initial offering price of $9.09 per unit. In addition, because of the
anti-dilution rights of the founder shares, any equity or equity-linked securities issued or deemed issued in connection with our initial
business combination would be disproportionately dilutive to our Class A common stock.
We may amend the terms of the rights in
a manner that may be adverse to holders with the approval by the holders of at least 50% of the then outstanding rights.
Our rights will be issued in registered form
under a right agreement between American Stock Transfer & Trust Company, as rights agent, and us. The right agreement provides that
the terms of the rights may be amended without the consent of any holder to cure any ambiguity or correct any defective provision. The
right agreement requires the approval by the holders of at least 50% of the then outstanding rights in order to make any change that adversely
affects the interests of the registered holders.
Our rights and founder shares may have an
adverse effect on the market price of our Class A common stock and make it more difficult to effectuate our initial business combination.
We issued rights convertible into 1,265,000
shares of our Class A common stock as part of the units offered in the IPO and, simultaneously with the closing of the IPO, we issued
in a private placement, private placement units, which consist of (i) an aggregate of 519,500 private placement shares, and (ii) private
placement rights to receive an aggregate of 51,950 shares of Class A common stock; we issued to the representative of the underwriters
101,200 shares of Class A common stock and underwriters warrants to purchase 632,500 shares of Class A common stock. Our initial stockholders
currently own an aggregate of 3,162,500 founder shares. The founder shares are convertible into shares of Class A common stock on
a one-for-one basis, subject to adjustment as set forth herein. In addition, if our sponsor or its affiliates, or any of our officers
or directors, makes any working capital loans, up to $1,500,000 of such loans may be converted into private placement-equivalent units
at a price of $10.00 per unit (which, for example, would result in the holders being issued 165,000 shares of Class A common
stock if $1,500,000 of notes were so converted since the 150,000 rights included in such units would result in the issuance of 15,000
shares upon the closing of our business combination), at the option of the lender. Such units would be identical to the private placement
units.
To the extent we issue shares of Class A
common stock to effectuate an initial business combination, the potential for the issuance of a substantial number of additional shares
of Class A common stock upon conversion of these rights or exercise of these warrants could make us a less attractive business combination
vehicle to a target business. Any such issuance will increase the number of issued and outstanding shares of our Class A common stock
and reduce the value of the shares of Class A common stock issued to complete the initial business combination. Therefore, our rights,
warrants and founder shares may make it more difficult to effectuate an initial business combination or increase the cost of acquiring
the target business.
The securities in which we invest the funds
held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the
per-share redemption amount received by public stockholders may be less than $10.10 per share.
The proceeds
held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in
money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S.
government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they
have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero
in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future
adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain
amendments to our amended and restated certificate of incorporation, our public stockholders are entitled to receive their pro-rata share
of the proceeds held in the trust account, plus any interest income, net of taxes paid or payable (less, in the case we are unable to
complete our initial business combination, $50,000 of interest). Negative interest rates could reduce the value of the assets held in
trust such that the per-share redemption amount received by public stockholders may be less than $10.10 per share.
The grant of registration rights to our
initial stockholders may make it more difficult to complete our initial business combination, and the future exercise of such rights may
adversely affect the market price of our Class A common stock.
Pursuant to an agreement to be entered into
concurrently with the issuance and sale of the securities in the IPO, our initial stockholders, officers and directors and their permitted
transferees can demand that we register the private placement units, the private placement shares, the private placement rights, the post
business combination shares, and the shares of Class A common stock issuable upon exercise of the founder shares and upon conversion
of the private placement rights held, or to
be held, by them and holders of securities
that may be issued upon conversion of working capital loans may demand that we register such securities. In addition, the representative
of the underwriters can make such demand with respect to up to the 101,200 shares of Class A common stock and 632,500 shares of Class
A common stock underlying the representative’s warrants. We will bear the cost of registering these securities. The registration
and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market
price of our Class A common stock. In addition, the existence of the registration rights may make our initial business combination
more costly or difficult to conclude. This is because the stockholders of the target business may increase the equity stake they seek
in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our Class A common
stock that is expected when the securities owned by our initial stockholders or holders of working capital loans or their respective permitted
transferees are registered.
Our rights agreement designates the courts
of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for
certain types of actions and proceedings that may be initiated by holders of our rights, which could limit the ability of right holders
to obtain a favorable judicial forum for disputes with our company.
Our rights agreement provides that, subject
to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the rights agreement,
including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be
the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum.
Notwithstanding the foregoing, these provisions
of the rights agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim
for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing
or otherwise acquiring any interest in any of our rights shall be deemed to have notice of and to have consented to the forum provisions
in our rights agreement. If any action, the subject matter of which is within the scope the forum provisions of the rights agreement,
is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York
(a “foreign action”) in the name of any holder of our rights, such holder shall be deemed to have consented to: (x) the
personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such
court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such right
holder in any such enforcement action by service upon such right holder’s counsel in the foreign action as agent for such right
holder. This choice-of-forum provision may limit a right holder’s ability
to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively,
if a court were to find this provision of our rights agreement inapplicable or unenforceable with respect to one or more of the specified
types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could
materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and
resources of our management and board of directors.
We are an emerging growth company within
the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth
companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with
other public companies.
We are an “emerging growth company”
within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being
required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result,
our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to
five years, although circumstances could cause us to lose that status earlier, including if the market value of our Class A common
stock held by non-affiliates exceeds $700 million as of any September 30 before that time, in which case we would no longer be an emerging
growth company as of the following September 30. We cannot predict whether investors will find our securities less attractive because
we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions,
the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities
and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when
a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has
opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards
used. Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting
companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited
financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of
our common stock held by non-affiliates exceeds $250 million as of the end of the prior September 30, or (2) our annual revenues exceeded
$100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as
of the prior September 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our
financial statements with other public companies difficult or impossible.
Compliance obligations under the Sarbanes-Oxley
Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources,
and increase the time and costs of completing an initial business combination.
Section 404 of the Sarbanes-Oxley Act
requires that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year
ending March 31, 2022. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify
as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement
on our internal control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required
to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting.
The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on
us as compared to other public companies because a target company with which we seek to complete our initial business combination may
not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the
internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete
any such business combination.
The nominal purchase price paid by our sponsor
for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial
business combination.
We offered and sold our units at an offering
price of $10.00 per unit and the amount in our trust account is initially anticipated to be $10.10 per public share, implying an initial
value of $10.10 per public share. However, prior to the IPO, our sponsor paid a nominal aggregate purchase price of $50,000 for the founder
shares, or approximately $0.017 per share. As a result, the value of the public shares sold in the IPO may be significantly diluted upon
the consummation of our initial business combination, when the founder shares are converted into public shares. For example, the following
table shows the dilutive effect of the founder shares on the implied value of the public shares upon the consummation of our initial business
combination, assuming that our equity value at that time is $123,337,500, which is the amount we would have for our initial business combination
in the trust account after payment of $4,427,500 of business combination marketing fees, assuming no interest is earned on the funds held
in the trust account, and no public shares are redeemed in connection with our initial business combination, and without taking into account
any other potential impacts on our valuation at such time, such as the trading price of our public shares, the business combination transaction
costs, any equity issued or cash paid to the target’s sellers or other third parties, or the target’s business itself, including
its assets, liabilities, management and prospects, as well as the value of our public and private warrants. At such valuation, each of
our shares of common stock would have an implied value of $7.51 per share upon consummation of our initial business combination, which
would be a 25.6% decrease as compared to the initial implied value per public share of $10.10 (the price per unit in the IPO, assuming
no value to the public rights).
Public shares |
|
|
12,650,000 |
|
Founder shares |
|
|
3,162,500 |
|
Representative’s shares |
|
|
101,200 |
|
Private placement shares |
|
|
519,500 |
|
Total shares |
|
|
16,433,200 |
|
Total funds in trust available for initial business combination (less business combination marketing fees) |
|
$ |
123,337,500 |
|
Initial implied value per public share |
|
$ |
10.10 |
|
Implied value per share upon consummation of initial business combination |
|
$ |
7.51 |
|
The foregoing does not take into account the
300,000 post business combination shares issuable to our directors and officers within 10 days following the business combination.
The value of the founder shares following
completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the
trading price of our common stock at such time is substantially less than $10.10 per share.
Upon the closing of the IPO, our sponsor and
I-Bankers had invested in us an aggregate of $5,245,000, comprised of the $50,000 purchase price for the founder shares and the $5,195,000
purchase price for the private placement units. Assuming a trading price of $10.10 per share upon consummation of our initial business
combination, the 3,162,500 founder shares, the 519,500 private placement shares and the 51,950 shares of Class A common stock underlying
private placement rights would have an aggregate implied value of $37,712,895. Even if the trading price of our Class A common stock was
as low as $1.40 per share, the value of the 3,162,500 founder shares, 519,500 private placement shares and 51,950 shares of Class A common
stock underlying private placement rights would be equal to the sponsor’s initial investment in us. As a result, our sponsor is
likely to be able to recoup its investment in us and make a substantial profit on that investment, even if our public shares have lost
significant value. Accordingly, our management team, which owns interests in our sponsor, may have an economic incentive that differs
from that of the public stockholders to pursue and consummate an initial business combination rather than to liquidate and to return all
of the cash in the trust to the public stockholders, even if that business combination were with a riskier or less-established target
business. For the foregoing reasons, you should consider our management team's financial incentive to complete an initial business combination
when evaluating whether to redeem your shares prior to or in connection with the initial business combination.
Our sponsor paid an aggregate of $50,000
for the founder shares, or approximately $0.017 per founder share. As a result of this low initial price, our sponsor, its affiliates
and our management team and advisors stand to make a substantial profit even if an initial business combination subsequently declines
in value or is unprofitable for our public stockholders.
As a result of the low acquisition cost of
our founder shares, our sponsor, its affiliates and our management team and advisors could make a substantial profit even if we select
and consummate an initial business combination with an acquisition target that subsequently declines in value or is unprofitable for
our public stockholders. Thus, such parties may have more of an economic incentive for us to enter into an initial business combination
with a riskier, weaker-performing or financially unstable business, or an entity lacking an established record of revenues or earnings,
than would be the case if such parties had paid the full offering price for their founder shares.
Unlike many other similarly structured blank
check companies, our initial stockholders will receive additional shares of Class A common stock if we issue shares to consummate
an initial business combination.
The founder shares will automatically convert
into Class A common stock at the time of our initial business combination, on a one-for-one basis, subject to adjustment as provided
herein. In the case that additional shares of Class A common stock, or equity-linked securities convertible or exercisable for Class A
common stock, are issued or deemed issued in excess of the amounts offered in this Annual Report and related to the closing of the initial
business combination, the ratio at which founder shares shall convert into Class A common stock will be adjusted so that the number
of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20%
of the total number of all outstanding shares of common stock upon completion of the initial business combination, excluding the placement
shares, the representative shares, the post business combination shares , and any shares or equity-linked securities issued, or to be
issued, to any seller in the business combination and any private placement-equivalent units and their
underlying securities issued to our sponsor
or its affiliates upon conversion of loans made to us. This is different from most other similarly structured blank check companies in
which the initial stockholder will only be issued an aggregate of 20% of the total number of shares to be outstanding prior to the initial
business combination. Additionally, the aforementioned adjustment will not take into account any shares of Class A common stock redeemed
in connection with the business combination. Accordingly, the holders of the founder shares could receive additional shares of Class A
common stock even if the additional shares of Class A common stock, or equity-linked securities convertible or exercisable for Class A
common stock, are issued or deemed issued solely to replace those shares that were redeemed in connection with the business combination.
The foregoing may make it more difficult and expensive for us to consummate an initial business combination.
General Risk Factors
Provisions in our amended and restated certificate
of incorporation and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future
for our Class A common stock and could entrench management.
Our amended and restated certificate of incorporation
contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. These
provisions include a staggered board of directors, removal of directors for cause only and the ability of the board of directors to designate
the terms of and issue new series of preferred shares, which may make the removal of management more difficult and may discourage transactions
that otherwise could involve payment of a premium over prevailing market prices for our securities.
We are also subject to anti-takeover provisions
under Delaware law, which could delay or prevent a change of control. Together these provisions may make the removal of management more
difficult and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.
Our amended and restated certificate of
incorporation requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against our directors,
officers, other employees or stockholders for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery
in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service
of process on such stockholder’s counsel, which may have the effect of discouraging lawsuits against our directors, officers, other
employees or stockholders.
Our amended and restated certificate of incorporation
requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against our directors, officers,
other employees or stockholders for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in
the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service
of process on such stockholder’s counsel except any action (A) as to which the Court of Chancery in the State of Delaware determines
that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent
to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive
jurisdiction of a court or forum other than the Court of Chancery, (C) for which the Court of Chancery does not have subject matter
jurisdiction, or (D) any action arising under the Securities Act, as to which the Court of Chancery and the federal district court
for the District of Delaware shall have concurrent jurisdiction. Any person or entity purchasing or otherwise acquiring any interest in
shares of our capital stock shall be deemed to have notice of and consented to the forum provisions in our amended and restated certificate
of incorporation. This choice of forum provision may make it more costly for a stockholder to bring a claim, and it may also limit a stockholder’s
ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees
or stockholders, which may discourage lawsuits with respect to such claims, although our stockholders cannot waive our compliance with
federal securities laws and the rules and regulations thereunder. Alternatively, if a court were to find the choice of forum provision
contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional
costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition.
Our amended and restated certificate of incorporation
provides that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions.
Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created
by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought
to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.
In addition, our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an
alternative forum, the federal district courts
of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint
asserting a cause of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder.
We note, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance
with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction
for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations
thereunder.
Our independent registered public accounting
firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going
concern.”
As of March 31, 2022, we had $877,099 in cash
and working capital of $655,693. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing
and acquisition plans. Management’s plans to address this need for capital through the IPO are discussed in the section of this
Annual Report titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We cannot
assure you that our plans to raise capital or to consummate an initial business combination will be successful. These factors, among others,
raise substantial doubt about our ability to continue as a going concern. The financial statements contained elsewhere in this Annual
Report do not include any adjustments that might result from our inability to consummate the IPO or our inability to continue as a going
concern.
If our management team pursues a company
with operations or opportunities outside of the United States for our initial business combination, we may face additional burdens
in connection with investigating, agreeing to and completing such combination, and if we effect such initial business combination,
we would be subject to a variety of additional risks that may negatively impact our operations.
If our management team pursues a company with
operations or opportunities outside of the United States for our initial business combination, we would be subject to risks associated
with cross-border business combinations, including in connection with investigating, agreeing to and completing our initial business
combination, conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators
or agencies and changes in the purchase price based on fluctuations in foreign exchange rates.
If we effect our initial business combination
with such a company, we would be subject to any special considerations or risks associated with companies operating in an international
setting, including any of the following:
|
• |
|
costs and difficulties inherent in managing cross-border business operations and complying with commercial and legal requirements of overseas markets; |
|
|
|
|
|
• |
|
rules and regulations regarding currency redemption; |
|
|
|
|
|
• |
|
complex corporate withholding taxes on individuals; |
|
|
|
|
|
• |
|
laws governing the manner in which future business combinations may be effected; |
|
|
|
|
|
• |
|
tariffs and trade barriers; |
|
|
|
|
|
• |
|
regulations related to customs and import/export matters; |
|
|
|
|
|
• |
|
longer payment cycles; |
|
|
|
|
|
• |
|
tax consequences; |
|
|
|
|
|
• |
|
currency fluctuations and exchange controls; |
|
|
|
|
|
• |
|
rates of inflation; |
|
|
|
|
|
• |
|
challenges in collecting accounts receivable; |
|
|
|
|
|
• |
|
cultural and language differences; |
|
|
|
|
|
• |
|
employment regulations; |
|
|
|
|
|
• |
|
crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars; |
|
|
|
|
|
• |
|
deterioration of political relations with the United States; |
|
|
|
|
|
• |
|
obligatory military service by personnel; and |
|
|
|
|
|
• |
|
government appropriation of assets. |
We may not be able to adequately address these
additional risks. If we were unable to do so, we may be unable to complete such initial business combination or, if we complete such initial
business combination, our operations might suffer, either of which may adversely impact our business, results of operations and financial
condition.
If our management following our initial
business combination is unfamiliar with U.S. securities laws, they may have to expend time and resources becoming familiar with
such laws, which could lead to various regulatory issues.
Following our initial business combination,
any or all of our management could resign from their positions as officers of the Company, and the management of the target business at
the time of the business combination could remain in place. Management of the target business may not be familiar with U.S. securities
laws. If new management is unfamiliar with U.S. securities laws, they may have to expend time and resources becoming familiar with such
laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.
Cyber incidents or attacks directed at us
could result in information theft, data corruption, operational disruption and/or financial loss.
We depend on digital technologies, including
information systems, infrastructure and cloud applications and services, including those of third parties with which we may deal. Sophisticated
and deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or
the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As
an early stage company without significant investments in data security protection, we may not be sufficiently protected against such
occurrences. We may not have sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to,
cyber incidents. It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business
and lead to financial loss.
Changes in laws or regulations, or a failure
to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial
business combination, and results of operations.
We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements.
Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations
and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our
business, investments and results of operations.
In addition, a failure to comply with applicable
laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate
and complete our initial business combination, and results of operations.